<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="EN" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Omega</journal-id><journal-id journal-id-type="iso-abbrev">ACS Omega</journal-id><journal-id journal-id-type="publisher-id">ao</journal-id><journal-id journal-id-type="coden">acsodf</journal-id><journal-title-group><journal-title>ACS Omega</journal-title></journal-title-group><issn pub-type="epub">2470-1343</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7860093</article-id><article-id pub-id-type="doi">10.1021/acsomega.0c05302</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Green Synthesis, Antioxidant, and Plant Growth Regulatory
Activities of Novel &#x003b1;-Furfuryl-2-alkylaminophosphonates</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Nadiveedhi</surname><given-names>Maheshwara
Reddy</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Nuthalapati</surname><given-names>Poojith</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Gundluru</surname><given-names>Mohan</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Yanamula</surname><given-names>Mohan Reddy</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Kallimakula</surname><given-names>Saritha Venkatareddy</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath6"><name><surname>Pasupuleti</surname><given-names>Visweswara Rao</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff5" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Avula</surname><given-names>Vijaya Kumar Reddy</given-names></name><xref rid="aff6" ref-type="aff">#</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Vallela</surname><given-names>Swetha</given-names></name><xref rid="aff6" ref-type="aff">#</xref></contrib><contrib contrib-type="author" id="ath9"><name><surname>Zyryanov</surname><given-names>Grigory Vasilievich</given-names></name><xref rid="aff6" ref-type="aff">#</xref><xref rid="aff7" ref-type="aff">&#x000b6;</xref></contrib><contrib contrib-type="author" id="ath10"><name><surname>Balam</surname><given-names>Satheesh Krishna</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath11"><name><surname>Cirandur</surname><given-names>Suresh Reddy</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Department
of Chemistry, <institution>Sri Venkateswara University</institution>, Tirupati 517502, Andhra Pradesh, <country>India</country></aff><aff id="aff2"><label>&#x02021;</label><institution>Sri
Ramachandra Institute of Higher Education and Research</institution>, Chennai 600116, Tamil Nadu, <country>India</country></aff><aff id="aff3"><label>&#x000a7;</label>DST-PURSE
Centre, <institution>Sri Venkateswara University</institution>, Tirupati 517502, Andhra Pradesh, <country>India</country></aff><aff id="aff4"><label>&#x02225;</label>Department
of Biotechnology, <institution>Sri Venkateswara University</institution>, Tirupati 517502, Andhra Pradesh, <country>India</country></aff><aff id="aff5"><label>&#x022a5;</label>Department
of Biomedical Sciences and Therapeutics, Faculty of Medicine and Health
Sciences, <institution>Universiti Malaysia Sabah</institution>, Kota Kinabalu 88400, Sabah, <country>Malaysia</country></aff><aff id="aff6"><label>#</label>Chemical
Engineering Institute, <institution>Ural Federal University</institution>, Yekaterinburg 620002, <country>Russian Federation</country></aff><aff id="aff7"><label>&#x000b6;</label>Ural
Division of the Russian Academy of Sciences, <institution>I. Ya. Postovskiy Institute of Organic Synthesis</institution>, 22 S. Kovalevskoy Street, Yekaterinburg 620219, <country>Russian Federation</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>csrsvu@gmail.com</email>.</corresp><corresp id="cor2"><label>*</label>Email: <email>pvrao@ums.edu.my</email>.</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>01</month><year>2021</year></pub-date><pub-date pub-type="collection"><day>02</day><month>02</month><year>2021</year></pub-date><volume>6</volume><issue>4</issue><fpage>2934</fpage><lpage>2948</lpage><history><date date-type="received"><day>30</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>18</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2021 The
Authors. Published by American
Chemical Society</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>The Authors</copyright-holder><license><license-p>This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_0011" id="ab-tgr1"/></p><p>A series of novel
&#x003b1;-furfuryl-2-alkylaminophosphonates have
been efficiently synthesized from the one-pot three-component classical
Kabachnik&#x02013;Fields reaction in a green chemical approach by addition
of an <italic>in situ</italic> generated dialkylphosphite to Schiff&#x02019;s
base of aldehydes and amines by using environmental and eco-friendly
silica gel supported iodine as a catalyst by microwave irradiation.
The advantage of this protocol is simplicity in experimental procedures
and products were resulted in high isolated yields. The synthesized
&#x003b1;-furfuryl-2-alkylaminophosphonates were screened to <italic>in vitro</italic> antioxidant and plant growth regulatory activities
and some are found to be potent with antioxidant and plant growth
regulatory activities. These <italic>in vitro</italic> studies have
been further supported by ADMET (absorption, distribution, metabolism,
excretion, and toxicity), quantitative structure&#x02013;activity relationship,
molecular docking, and bioactivity studies and identified that they
were potentially bound to the GLN340 amino acid residue in chain C
of 1DNU protein and TYR597 amino acid residue in chain A of 4M7E protein,
causing potential exhibition of antioxidant and plant growth regulatory
activities. Eventually, title compounds are identified as good blood&#x02013;brain
barrier (BBB)-penetrable compounds and are considered as proficient
central nervous system active and neuroprotective antioxidant agents
as the neuroprotective property is determined with BBB penetration
thresholds.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ao0c05302</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ao0c05302</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p>Organophosphorus
chemistry research bestowed an elegant locus to
&#x003b1;-aminophosphonates as they have exhilarated with potential
antioxidant,<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> antifungal,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> antibacterial,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> antidiabetic,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> anticancer,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> antiviral,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> antitumor,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> cytotoxic,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> antiproliferative,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> antibiotic,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> antithrombotic,<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> peptidomimetic,<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> catalytic antibodies hapten,<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> neuroactive
enzyme inhibiting, and anti-bone resorption<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> activities. As they are tetrahedral transition-state mimics, they
are identified as HIV protease,<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> synthase,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> serine hydrolase,<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> and UDP-galactopyranose mutase<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> inhibitors.
They have also been identified as surrogates of both natural and synthetic
&#x003b1;-amino acids<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> as constituted with
significant motifs in medicine. In agriculture, phosphorus is identified
as an essential element<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup> and is widely used
in the production of crop fertilizers. They find their use as insecticides,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> plant growth regulators,<sup><xref ref-type="bibr" rid="ref22">22</xref>&#x02212;<xref ref-type="bibr" rid="ref24">24</xref></sup> herbicides,<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> pesticides,<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> fungicides,<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> and in photosynthesis as ADP and ATP. In the
industry, they are used as additive polymers,<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> surfactants,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> lubricants,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> surface treaters on metals,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> and flame retardants.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> In organic
chemistry,<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> they have been used as catalysts<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> in coupling<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> and
complex reactions<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> and also as catalytic
promoters.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Many aminophosphonic acids/peptides/esters
from both synthetic and natural origin have displayed an extensive
array of biological activities.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> They
act as substrates in the synthesis and development of impending drugs
against various metabolic disorders.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p><p>Owing to these, the synthesis of &#x003b1;-aminophosphonates had
grown more inquisitiveness in medicinal chemistry researchers to study
their structure&#x02013;activity relationship and to design some more
potential libraries to the existing repositories. Although a number
of synthetic methodologies have been reported to construct bioactive
&#x003b1;-aminophosphonates,<sup><xref ref-type="bibr" rid="ref39">39</xref>&#x02212;<xref ref-type="bibr" rid="ref42">42</xref></sup> the nucleophilic phosphite addition to Schiff&#x02019;s
base is the utmost prevailing and modest method. Here, certain active
catalysts such as titanium dioxide, boric acid, sulfonic acid functionalized
ionic liquid, nanoporous AlSBA-15,<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> Magnetic
BaFe<sub>12</sub>O<sub>19</sub>/Al<sub>2</sub>O<sub>3</sub>,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> and silica sulfuric acid<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> are used with conventional heating, sonication, microwave
irradiation in organic solvents,<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> and
even with simple grinding. Among them, reactions stimulated with ultrasonic/microwave
irradiation led to the specific attention as these energizing techniques
advance the reaction and complete it in less time under trivial conditions
and produces high yields and also more pronounced scientifically.
Concerning the vitality of furfuryl and tetrahydrofurfuryl groups
in pharmaceuticals, fibers, and perfumes,<sup><xref ref-type="bibr" rid="ref47">47</xref>&#x02212;<xref ref-type="bibr" rid="ref51">51</xref></sup> one-pot microwave Kabachnik&#x02013;Fields synthesis
of some novel and structurally diversified &#x003b1;-furfuryl-2-ethyl
aminophosphonates (<bold>5a&#x02013;j</bold>) has been designed through
the reaction of aryl aldehydes, furfurylamine, and dialkyl phosphonates
(<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>). The synthesized
&#x003b1;-furfuryl-2-alkylaminophosphonates were structurally confirmed
by physical characterization and spectral studies, and their antioxidant
and plant growth regulatory activities have been evaluated by <italic>in silico</italic> and <italic>in vitro</italic> methods. Eventually,
herein we describe the microwave-supported synthesis, spectral and
physical characterization, and biological activity evaluation of novel
furfurylamine-based &#x003b1;-aminophosphonates. The additional studies
such as molecular docking, quantitative structure&#x02013;activity
relationship (QSAR), and ADMET (absorption, distribution, metabolism,
excretion, and toxicity) performed to study their bioactivity properties
infer that the bioactive proficiency of <bold>5a&#x02013;j</bold> has
been administrated through a stereogenic &#x003b1;-carbon&#x02019;s configuration
bonded to phosphorus.</p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>Synthesis of &#x003b1;-Furfuryl-2-alkylaminophosphonates
(<bold>5a&#x02013;j</bold>)</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_0007" id="gr6" position="float"/></fig></sec><sec id="sec2"><label>2</label><title>Results and Discussion</title><sec id="sec2.1"><label>2.1</label><title>Chemistry</title><p>Synthesis
of diethyl ((((furan-2-ylmethyl)amino)
(4-hydroxy-3-methoxyphenyl)methyl) phosphonate) (<bold>5a</bold>)
has been accomplished by two different reaction pathways A and B.
Path A involves a straight one-pot and three-component, SiO<sub>2</sub>&#x02013;I<sub>2</sub>-catalyzed Kabachnik&#x02013;Fields reaction
of vanillin (<bold>2a</bold>), furfurylamine (<bold>1</bold>), and
diethylphosphite (<bold>3a</bold>) promoted by microwave irradiation.
In path B, the reaction is carried out through the addition of diethylphosphite
(<bold>3a</bold>) to the vanillin-derived Schiff base, vanillinidene-furfurylamine
(<bold>4</bold>) (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>); by following the same procedure, the remaining analogues
of the series (<bold>5b&#x02013;j</bold>) have been synthesized.</p><sec id="sec2.1.1"><label>2.1.1</label><title>Optimization of Reaction Conditions for
the Synthesis of <bold>5a</bold></title><p>Both reactions were run
under microwave irradiation at different conditions and observed that
best product yields were obtained in both the pathways at 40 &#x000b0;C
and 600 W (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).
Among the two reaction pathways, better product yields were obtained
in path A in less time because of the synergic formation of Schiff&#x02019;s
base from vanillin, furfurylamine, and addition of phosphite to it.
However, in path B, water formed during the formation of imine hydrolyzes
the imine back to aldehyde that results in lower yields. We observed
that the reaction goes slowly and takes 6h to complete without any
catalyst. When the reaction was conducted with different catalysts
such as Al<sub>2</sub>O<sub>3</sub>, SiO<sub>2</sub>, Al(OTf)<sub>3</sub>, and BF<sub>3</sub>&#x000b7;Et<sub>2</sub>O, moderate product
yields (35&#x02013;45%) were obtained. When the reaction was conducted
in 10 mol % of SiO<sub>2</sub>&#x02013;I<sub>2</sub>, a great increase
in the rate of reaction yields in lesser times takes place. At the
outset, it was thought that SiO<sub>2</sub>&#x02013;I<sub>2</sub> was
acquainted for catalytic support; besides, kinetic studies have revealed
that it enhances the rate of reaction because of its acidic characteristic
and ease of binding of silicone with several atoms of the substrates.
Recently, several research groups have utilized some silica-supported
catalysts such as SiO<sub>2</sub>&#x02013;CeCl<sub>2</sub> and SiO<sub>2</sub>&#x02013;ZnCl<sub>2</sub><sup><xref ref-type="bibr" rid="ref52">52</xref></sup> effectively
to synthesize &#x003b1;-amino/carbamoyl/carbamothioyl phosphonates.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Optimization of Synthesis of <bold>5a</bold><xref rid="t1fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/><col align="left"/><col align="char" char="."/><col align="char" char="."/></colgroup><thead><tr><th style="border:none;" align="center">temperature
(&#x000b0;C)</th><th style="border:none;" align="center" char=".">microwave
irradiation (W)</th><th style="border:none;" align="center">catalyst (10&#x000a0;mol&#x000a0;%)</th><th style="border:none;" align="center" char=".">time
(min)</th><th style="border:none;" align="center" char=".">isolated
yield (%)<xref rid="t1fn2" ref-type="table-fn">b</xref></th></tr></thead><tbody><tr><td style="border:none;" align="left">25</td><td style="border:none;" align="char" char=".">100</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">10.24</td></tr><tr><td style="border:none;" align="left">25</td><td style="border:none;" align="char" char=".">200</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">12.49</td></tr><tr><td style="border:none;" align="left">25</td><td style="border:none;" align="char" char=".">300</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">15.17</td></tr><tr><td style="border:none;" align="left">25</td><td style="border:none;" align="char" char=".">400</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">20.66</td></tr><tr><td style="border:none;" align="left">25</td><td style="border:none;" align="char" char=".">500</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">25.48</td></tr><tr><td style="border:none;" align="left">25</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">32.59</td></tr><tr><td style="border:none;" align="left">25</td><td style="border:none;" align="char" char=".">700</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">32.38</td></tr><tr><td style="border:none;" align="left">25</td><td style="border:none;" align="char" char=".">800</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">20.27</td></tr><tr><td style="border:none;" align="left">30</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">32.69</td></tr><tr><td style="border:none;" align="left">40</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">35.74</td></tr><tr><td style="border:none;" align="left">50</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">35.93</td></tr><tr><td style="border:none;" align="left">60</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">&#x0005f;</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">25.87</td></tr><tr><td style="border:none;" align="left">40</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">Al<sub>2</sub>O<sub>3</sub></td><td style="border:none;" align="char" char=".">45</td><td style="border:none;" align="char" char=".">51.79</td></tr><tr><td style="border:none;" align="left">40</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">SiO<sub>2</sub></td><td style="border:none;" align="char" char=".">42</td><td style="border:none;" align="char" char=".">66.30</td></tr><tr><td style="border:none;" align="left">40</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">Al(OTf)<sub>3</sub></td><td style="border:none;" align="char" char=".">40</td><td style="border:none;" align="char" char=".">70.52</td></tr><tr><td style="border:none;" align="left">40</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">nano Al<sub>2</sub>O<sub>3</sub></td><td style="border:none;" align="char" char=".">43</td><td style="border:none;" align="char" char=".">57.95</td></tr><tr><td style="border:none;" align="left">40</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">BF<sub>3</sub>EtO</td><td style="border:none;" align="char" char=".">40</td><td style="border:none;" align="char" char=".">63.41</td></tr><tr><td style="border:none;" align="left">40</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">I<sub>2</sub></td><td style="border:none;" align="char" char=".">35</td><td style="border:none;" align="char" char=".">76.54</td></tr><tr><td style="border:none;" align="left">40</td><td style="border:none;" align="char" char=".">600</td><td style="border:none;" align="left">SiO<sub>2</sub>&#x02013;I<sub>2</sub></td><td style="border:none;" align="char" char=".">20</td><td style="border:none;" align="char" char=".">92.29</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Reaction
conditions: diethyl phosphite
(<bold>3a</bold>), vanillin-derived Schiff base (<bold>4</bold>),
and SiO<sub>2</sub>&#x02013;I<sub>2</sub> as the catalyst.</p></fn><fn id="t1fn2"><label>b</label><p>Isolated yield.</p></fn></table-wrap-foot></table-wrap><p>In addition, iodine was used as a catalyst owing to
its abundant
availability and low cost, ease of handling, stability, and use in
numerous chemical transformations.<sup><xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> Further, the
catalyst mixture SiO<sub>2</sub>&#x02013;I<sub>2</sub> was prepared
from iodine and silica gel (100&#x02013;200 mesh) in a 2:1 ratio. It
worked as a heterogeneous catalyst and conveniently handled and separated
from the reaction mixture through filtration for reuse and is environment-friendly.
To our best knowledge, the SiO<sub>2</sub>&#x02013;I<sub>2</sub> catalyst
has not been reported to synthesize &#x003b1;-aminophosphonates, and
hence, we have explored the one-pot and three-component Kabachnik&#x02013;Fields
synthesis of &#x003b1;-furfuryl-2-alkylamino-phosphonates under heterogeneous
catalytic action of SiO<sub>2</sub>&#x02013;I<sub>2</sub> in association
with solvent-free, microwave irradiation conditions.</p><p>Hence,
the finest conditions for reacting 2.0 mmol of aldehyde
(<bold>2</bold>) and furfurylamine (<bold>1</bold>) with 2.1 mmol
of dialkylphosphite (<bold>3</bold>) and 10 mol % of SiO<sub>2</sub>&#x02013;I<sub>2</sub> under microwave irradiation and neat conditions
have accomplished and produced <bold>5a&#x02013;j</bold> in 83&#x02013;92%
yields (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). It
is observed that this reaction method is applicable to a wide range
of aromatic aldehydes (electron-rich as well as electron-deficient)
and diethyl and dimethyl phosphites and that the reactions proceed
smoothly in 20&#x02013;30 min and produced <bold>5a&#x02013;j</bold> in excellent isolated yields. Eventually, it is noticed that the
effect of electron-withdrawing groups on the carbonyl compound decreases
the product yield and also increases the reaction time, while the
effect of electron-releasing groups on carbonyl compound increases
the product yield and decreases the reaction time.</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Reaction Time and Yield of the Products <bold>5a&#x02013;j</bold></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col/><col/><col/></colgroup><thead><tr><th style="border:none;" align="center">entry</th><th style="border:none;" align="center">reaction time (min)</th><th style="border:none;" align="center">isolated yield (%)</th></tr></thead><tbody><tr><td style="border:none;"><bold>5a</bold></td><td style="border:none;">20</td><td style="border:none;">92.35</td></tr><tr><td style="border:none;"><bold>5b</bold></td><td style="border:none;">22</td><td style="border:none;">90.42</td></tr><tr><td style="border:none;"><bold>5c</bold></td><td style="border:none;">15</td><td style="border:none;">95.28</td></tr><tr><td style="border:none;"><bold>5d</bold></td><td style="border:none;">22</td><td style="border:none;">89.41</td></tr><tr><td style="border:none;"><bold>5e</bold></td><td style="border:none;">15</td><td style="border:none;">96.53</td></tr><tr><td style="border:none;"><bold>5f</bold></td><td style="border:none;">25</td><td style="border:none;">85.17</td></tr><tr><td style="border:none;"><bold>5g</bold></td><td style="border:none;">20</td><td style="border:none;">90.34</td></tr><tr><td style="border:none;"><bold>5h</bold></td><td style="border:none;">25</td><td style="border:none;">83.76</td></tr><tr><td style="border:none;"><bold>5i</bold></td><td style="border:none;">15</td><td style="border:none;">93.89</td></tr><tr><td style="border:none;"><bold>5j</bold></td><td style="border:none;">22</td><td style="border:none;">85.06</td></tr></tbody></table></table-wrap></sec><sec id="sec2.1.2"><label>2.1.2</label><title>Plausible Reaction Mechanism for the Synthesis
of <bold>5a&#x02013;j</bold></title><p>Obviously, this reaction is a
multistep procedure with the transition state having a quite complex
mechanism (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). In fact, in the first step, the catalyst has greatly promoted
the reaction by the virtue of acidic nature of silicon, is well influenced
by iodine by withdrawing electrons from silica, and activates electrophilically
the carbonyl carbon of the aldehyde (<bold>2</bold>), which facilitates
nucleophilic substitution by the amine (<bold>1</bold>) to form the
imine (<bold>4</bold>).</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Mechanism for SiO<sub>2</sub>&#x02013;I<sub>2</sub>-catalyzed synthesis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_0002" id="gr1" position="float"/></fig><p>Because its formation
is a reversible process, it is trapped immediately
by the catalyst as a four-membered imine&#x02013;phosphite&#x02013;SiO<sub>2</sub>&#x02013;I<sub>2</sub> complex transition state (<bold>4ts</bold>). Formation of <bold>4ts</bold> not only prevents hydrolysis of
the imine substrate (<bold>4</bold>) to the amine (<bold>1</bold>)
and aldehyde (<bold>2</bold>) by water formed during the condensation
of amine (<bold>1</bold>) and aldehyde that also force the reaction
forward. The SiO<sub>2</sub>&#x02013;I<sub>2</sub> catalyst coordinates
to the nitrogen atom of <bold>4ts</bold> renders it more electron
rich by attracting the electron density of imino bond and facilitates
concerted break-up of <bold>4ts</bold> in such a way as to lead to
the nucleophilic addition of phosphino phosphorus to the iminocarbon
atom and electrophilic addition of hydrogen to the iminonitrogen atom
to form &#x003b1;-aminophosphonate (<bold>5</bold>) with simultaneous
release of the catalyst.</p></sec></sec><sec id="sec2.2"><label>2.2</label><title>Antioxidant
Activity</title><p>The title compounds
were screened for <italic>in vitro</italic> plant growth and antioxidant
activities and supported by molecular docking studies. Compounds which
inhibit the oxidation are known to be antioxidants. If oxidation takes
place, then there is a chance of formation of free radicals, which
leads to chain reactions that may damage the active cells. Hence,
the main aim of the antioxidants is to inhibit generation of free
radicals, thereby protecting the active cells.<sup><xref ref-type="bibr" rid="ref55">55</xref>&#x02212;<xref ref-type="bibr" rid="ref58">58</xref></sup> To evaluate the capacity of antioxidants,
different types of methods are developed, and among them, 1,1-diphenyl-2-picrylhydrazyl
(DPPH) and H<sub>2</sub>O<sub>2</sub> methods are more popular and
effective. Hence, the synthesized novel &#x003b1;-furfuryl-2-ethylaminophosphonates
(<bold>5a&#x02013;j</bold>) are screened for antioxidant activity by
these methods.</p><sec id="sec2.2.1"><label>2.2.1</label><title>DPPH Radical Scavenging
Assay</title><p>Compounds <bold>5a&#x02013;j</bold> were subjected to
free radical scavenging <italic>in vitro</italic> by the DPPH radical
assay;<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> the IC<sub>50</sub> value denotes
the concentration of the compound
that inhibits 50% process of oxidation and is obtained by plotting
the concentration <italic>versus</italic> percentage of inhibition
graph and the obtained IC<sub>50</sub> values shown against their
compounds (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Among the synthesized compounds <bold>5a&#x02013;j</bold>, <bold>5e</bold> (IC<sub>50</sub> = 35.23) showed higher bioactivity compared
to standard ascorbic acid (IC<sub>50</sub> = 39.42). Also, <bold>5c</bold> (38.03) and <bold>5i</bold> (38.72) showed good results in comparison
to ascorbic acid. Perhaps their significant activities are due to
the presence of electron-donating methoxy (&#x02212;OCH<sub>3</sub>) and hydroxy (&#x02212;OH) substitutions in <bold>5c</bold>, <bold>5i</bold> at meta and para position, respectively. In <bold>5e</bold>, the two methoxy groups at the meta position being less conjugated
than the methoxy group located at the para position delivers additional
electron density to overcome oxidation. The identical process in hydroxyl
group present in <bold>5c</bold> and <bold>5i,</bold> but which are
less compared to methoxy group, hydroxyl group and hence they have
shown less antioxidant activity than <bold>5e</bold>. Furthermore,
the presence of electron-withdrawing groups in <bold>5f</bold> (fluorine
at the ortho position and bromine at the meta position) decreases
the availability of electrons and is responsible for the lower activity.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>DPPH radical
scavenging activity of <bold>5a&#x02013;j</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_0003" id="gr2" position="float"/></fig></sec><sec id="sec2.2.2"><label>2.2.2</label><title>H<sub>2</sub>O<sub>2</sub> Radical Scavenging
Assay</title><p>In practice, the hydroxyl free radical scavenging assay
of <bold>5a&#x02013;j</bold> has been performed by deoxyribose method<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> and was referenced to ascorbic acid standard.
In H<sub>2</sub>O<sub>2</sub> radical scavenging assay, the compound <bold>5e</bold> (IC<sub>50</sub> = 35.38) exhibited noteworthy activity
than the standard ascorbic acid (39.57), whereas compounds <bold>5c</bold> (37.03) and <bold>5i</bold> (38.72) exhibit moderate activities
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). Here also,
the same structure&#x02013;activity has been observed among the series
of compounds as noticed in the DPPH radical scavenging assay. The
results obtained from DPPH and H<sub>2</sub>O<sub>2</sub> free radical
scavenging assays followed the linear correlation and is comparable
to each other. It is not necessary that the OH group alone shows antioxidant
activity. The concept of electron donor and acceptor also plays a
very important role in the redox reactions. Therefore, any functional
group which is capable of donating electrons may act as a good antioxidant.
Among the synthesized title compounds, <bold>5c</bold>, <bold>5e</bold>, and <bold>5i</bold> showed relatively higher antioxidant activity
potentiality compared to standard ascorbic acid.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>H<sub>2</sub>O<sub>2</sub> radical scavenging activity of <bold>5a&#x02013;j</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_0004" id="gr3" position="float"/></fig></sec></sec><sec id="sec2.3"><label>2.3</label><title>Plant Growth Activity</title><p>As organophosphorus
compounds are bioactive toward both animals and plants and in such
aminophosphonates are comparatively more potent than glyphosate in
terms of biological activity. It is analyzed and identified that the
biological activity of title compounds intensely correlates with the
lipophilic characteristic of Trakephon and hence also resembles the
plant growth regulatory activity.<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> Therefore,
it is precisely credible that the action of title compounds is linked
with distracting plant membrane&#x02019;s function as proposed by many
researchers. Based on this notion, we have analyzed the effect of
prepared &#x003b1;-furfuryl-2-ethylaminophosphonates (<bold>5a&#x02013;j</bold>) differentiated by the nature of groups substituted on the phosphoryl
phosphorus and carbonyl carbon atoms and hence indicating diverse
polarity and hydrophobicity properties. Their plant growth regulatory
activity was tested on roots and shoots of aquatic plant <italic>sorghum bicolor</italic>, using the technique of Smith and
Fowden.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup></p><p>The results demonstrated
that all the compounds (<bold>5a&#x02013;j</bold>) clearly influenced
the growth of the plant roots as well as shoots, but their effect
on shoots is slightly less than that on the roots. Compound <bold>5c</bold> at 100 ppm showed highest root length (7.06 cm), and compound <bold>5e</bold> showed highest shoot length (1.96 cm). Further the point
of structure&#x02013;activity relationships, compounds substituted
with electron-releasing groups in the aromatic ring (<bold>5c</bold>, <bold>5f</bold>, and <bold>5j</bold>) promoted growth, while those
substituted with electron-withdrawing groups (<bold>5f</bold>) inhibit
the growth of the root. However, in the case of <bold>5d</bold> and <bold>5j</bold>, the presence of both electron-withdrawing and hydroxyl
groups showed moderate results. In the case of effect on shoot lengths,
all the compounds showed mostly equal effect. With respect to the
effect of concentration of the compound in solution, plant growth
also increases with the increase of concentration of the compound.
The results are represented in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Plant growth regulatory activity of compounds <bold>5a&#x02013;j</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_0005" id="gr4" position="float"/></fig></sec><sec id="sec2.4"><label>2.4</label><title>Molecular
Docking Studies</title><p>The <italic>in vitro</italic> DPPH and H<sub>2</sub>O<sub>2</sub> radical scavenging
activity and plant growth regulatory activity of <bold>5a&#x02013;j</bold> have been supported by their binding potentialities against the
considered enzymatic protein chains as revealed based on molecular
docking studies. Here, the molecular docking was executed for the
structures of <bold>5a&#x02013;j</bold> against the target protein
receptors in chain C of 1DNU (human myeloperoxidase&#x02013;thiocyanate
complex) protein and chain A of 4M7E (BL-induced activation of the
BRI1&#x02013;BAK1 complex) protein, respectively, for the antioxidant
and plant growth regulatory activities to study their protein&#x02013;ligand
binding interactions.</p><p>The potential binding modes of amino acid
residues against hydrogen bond acceptor and donor atoms of <bold>5a&#x02013;j</bold> and their docking poses are presented in <xref rid="tbl3" ref-type="other">Tables <xref rid="tbl3" ref-type="other">3</xref></xref>&#x02013;<xref rid="tbl6" ref-type="other">6</xref>. The binding specificity of <bold>5a&#x02013;j</bold> with chain C (containing 466 amino acids) of 1DNU (myeloperoxidase)
protein has confirmed their antioxidant potentiality as they were
intensely bound with the glutamine amino acid residue (GLN340) located
at the 340 position of the amino acid series in the chain. This assures
the core interaction of synthesized compounds at the central position
of chain C, which is a valid consideration to support antioxidant
activity <italic>in vitro</italic>.</p><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><title>Potential Protein&#x02013;Ligand
Interactions
of <bold>5a&#x02013;j</bold> with Chain C of Protein 1DNU at GLN340
Amino Acid Residue<xref rid="t3fn1" ref-type="table-fn">a</xref></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_0009" id="gr7" position="float"/><table-wrap-foot><fn id="t3fn1"><label>a</label><p>Docking poses of <bold>5a&#x02013;j</bold>, GLN340 in chain C of 1DNU protein and chain C
of 1DNU protein (in
order&#x02014;top left to bottom right).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl4" position="float"><label>Table 4</label><caption><title>Molecular Docking Interactions of <bold>5a&#x02013;j</bold> with Chain C of Protein 1DNU at GLN340 Amino Acid
Residue</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="left"/><col align="char" char="."/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">S. no.</th><th style="border:none;" align="center" char=".">cluster number</th><th style="border:none;" align="center" char=".">cluster rank</th><th style="border:none;" align="center" char=".">binding energy (kcal/mol)</th><th style="border:none;" align="center" char=".">no. of hydrogen
bonds</th><th style="border:none;" align="center" char=".">H-bond ligand atoms</th><th style="border:none;" align="center" char=".">H-bond receptor atoms</th><th style="border:none;" align="center">binding interaction</th><th style="border:none;" align="center" char=".">bond length
(&#x000c5;)</th><th style="border:none;" align="center">H-bond type</th></tr></thead><tbody><tr><td style="border:none;" align="left"><bold>5a</bold></td><td style="border:none;" align="char" char=".">4</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">&#x02013;8.2531</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P=O)&#x000b7;&#x000b7;&#x000b7;(HN)GLN340</td><td style="border:none;" align="char" char=".">2.4025</td><td style="border:none;" align="left">donor</td></tr><tr><td style="border:none;" align="left"><bold>5b</bold></td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">4</td><td style="border:none;" align="char" char=".">&#x02013;9.2938</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P=O)&#x000b7;&#x000b7;&#x000b7;(HN)GLN340</td><td style="border:none;" align="char" char=".">2.4223</td><td style="border:none;" align="left">donor</td></tr><tr><td style="border:none;" align="left"><bold>5c</bold></td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">&#x02013;8.2422</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P=O)&#x000b7;&#x000b7;&#x000b7;(HN)GLN340</td><td style="border:none;" align="char" char=".">2.3590</td><td style="border:none;" align="left">donor</td></tr><tr><td style="border:none;" align="left"><bold>5d</bold></td><td style="border:none;" align="char" char=".">5</td><td style="border:none;" align="char" char=".">5</td><td style="border:none;" align="char" char=".">&#x02013;8.6906</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P=O)&#x000b7;&#x000b7;&#x000b7;(HN)GLN340</td><td style="border:none;" align="char" char=".">2.1219</td><td style="border:none;" align="left">donor</td></tr><tr><td style="border:none;" align="left"><bold>5e</bold></td><td style="border:none;" align="char" char=".">4</td><td style="border:none;" align="char" char=".">3</td><td style="border:none;" align="char" char=".">&#x02013;9.2858</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P=O)&#x000b7;&#x000b7;&#x000b7;(HN)GLN340</td><td style="border:none;" align="char" char=".">2.3019</td><td style="border:none;" align="left">donor</td></tr><tr><td style="border:none;" align="left"><bold>5f</bold></td><td style="border:none;" align="char" char=".">19</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">&#x02013;8.0713</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand[P=O]&#x000b7;&#x000b7;&#x000b7;(HN)GLN340</td><td style="border:none;" align="char" char=".">2.4743</td><td style="border:none;" align="left">donor</td></tr><tr><td style="border:none;" align="left"><bold>5g</bold></td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">&#x02013;7.7212</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand[P=O]&#x000b7;&#x000b7;&#x000b7;(HN)GLN340</td><td style="border:none;" align="char" char=".">2.3626</td><td style="border:none;" align="left">donor</td></tr><tr><td style="border:none;" align="left"><bold>5h</bold></td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">&#x02013;8.2572</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P=O)&#x000b7;&#x000b7;&#x000b7;(HN)GLN340</td><td style="border:none;" align="char" char=".">2.0139</td><td style="border:none;" align="left">donor</td></tr><tr><td style="border:none;" align="left"><bold>5i</bold></td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">11</td><td style="border:none;" align="char" char=".">&#x02013;8.3254</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P=O)&#x000b7;&#x000b7;&#x000b7;(HN)GLN340</td><td style="border:none;" align="char" char=".">1.9604</td><td style="border:none;" align="left">donor</td></tr><tr><td style="border:none;" align="left"><bold>5j</bold></td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">&#x02013;8.4110</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P=O)&#x000b7;&#x000b7;&#x000b7;(HN)GLN340</td><td style="border:none;" align="char" char=".">2.3885</td><td style="border:none;" align="left">donor</td></tr></tbody></table></table-wrap><table-wrap id="tbl5" position="float"><label>Table 5</label><caption><title>Potential Protein&#x02013;Ligand Interactions
of <bold>5a&#x02013;j</bold> with Chain A of Protein 4M7E at TYR597
Amino Acid Residue<xref rid="t5fn1" ref-type="table-fn">a</xref></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_0010" id="gr8" position="float"/><table-wrap-foot><fn id="t5fn1"><label>a</label><p>Docking poses of <bold>5a&#x02013;j</bold>, TYR597 in chain A of 4M7E protein and chain A
of 4M7E protein (in
order&#x02014;top left to bottom right).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl6" position="float"><label>Table 6</label><caption><title>Molecular Docking Interactions of <bold>5a&#x02013;j</bold> with Chain A of Protein 4M7E at TYR597 Amino Acid
Residue</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="left"/><col align="char" char="."/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">S. no.</th><th style="border:none;" align="center" char=".">cluster number</th><th style="border:none;" align="center" char=".">cluster rank</th><th style="border:none;" align="center" char=".">binding energy (kcal/mol)</th><th style="border:none;" align="center" char=".">no. of hydrogen
bonds</th><th style="border:none;" align="center" char=".">H-bond ligand atoms</th><th style="border:none;" align="center" char=".">H-bond receptor atoms</th><th style="border:none;" align="center">binding interaction</th><th style="border:none;" align="center" char=".">bond length
(&#x000c5;)</th><th style="border:none;" align="center">H-bond type</th></tr></thead><tbody><tr><td style="border:none;" align="left"><bold>5a</bold></td><td style="border:none;" align="char" char=".">2</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">&#x02013;8.0654</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P&#x02013;C(H)&#x02013;NH)&#x000b7;&#x000b7;&#x000b7;(O&#x02013;H)TYR597</td><td style="border:none;" align="char" char=".">1.9397</td><td style="border:none;" align="left">acceptor</td></tr><tr><td style="border:none;" align="left"><bold>5b</bold></td><td style="border:none;" align="char" char=".">33</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">&#x02013;8.1484</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P&#x02013;C(H)&#x02013;NH)&#x000b7;&#x000b7;&#x000b7;(O&#x02013;H)TYR597</td><td style="border:none;" align="char" char=".">1.9236</td><td style="border:none;" align="left">acceptor</td></tr><tr><td style="border:none;" align="left"><bold>5c</bold></td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">&#x02013;7.9312</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P&#x02013;C(H)&#x02013;NH)&#x000b7;&#x000b7;&#x000b7;(O&#x02013;H)TYR597</td><td style="border:none;" align="char" char=".">2.1007</td><td style="border:none;" align="left">acceptor</td></tr><tr><td style="border:none;" align="left"><bold>5d</bold></td><td style="border:none;" align="char" char=".">6</td><td style="border:none;" align="char" char=".">6</td><td style="border:none;" align="char" char=".">&#x02013;7.9150</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P&#x02013;C(H)&#x02013;NH)&#x000b7;&#x000b7;&#x000b7;(O&#x02013;H)TYR597</td><td style="border:none;" align="char" char=".">2.3359</td><td style="border:none;" align="left">acceptor</td></tr><tr><td style="border:none;" align="left"><bold>5e</bold></td><td style="border:none;" align="char" char=".">20</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">&#x02013;7.8425</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P&#x02013;C(H)&#x02013;NH)&#x000b7;&#x000b7;&#x000b7;(O&#x02013;H)TYR597</td><td style="border:none;" align="char" char=".">2.7589</td><td style="border:none;" align="left">acceptor</td></tr><tr><td style="border:none;" align="left"><bold>5f</bold></td><td style="border:none;" align="char" char=".">40</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">&#x02013;7.6491</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P&#x02013;C(H)&#x02013;NH)&#x000b7;&#x000b7;&#x000b7;(O&#x02013;H)TYR597</td><td style="border:none;" align="char" char=".">2.0703</td><td style="border:none;" align="left">acceptor</td></tr><tr><td style="border:none;" align="left"><bold>5g</bold></td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">3</td><td style="border:none;" align="char" char=".">&#x02013;7.6353</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P&#x02013;C(H)&#x02013;NH)&#x000b7;&#x000b7;&#x000b7;(O&#x02013;H)TYR597</td><td style="border:none;" align="char" char=".">2.3484</td><td style="border:none;" align="left">acceptor</td></tr><tr><td style="border:none;" align="left"><bold>5h</bold></td><td style="border:none;" align="char" char=".">2</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">&#x02013;7.8134</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P&#x02013;C(H)&#x02013;NH)&#x000b7;&#x000b7;&#x000b7;(O&#x02013;H)TYR597</td><td style="border:none;" align="char" char=".">2.3462</td><td style="border:none;" align="left">acceptor</td></tr><tr><td style="border:none;" align="left"><bold>5i</bold></td><td style="border:none;" align="char" char=".">21</td><td style="border:none;" align="char" char=".">2</td><td style="border:none;" align="char" char=".">&#x02013;7.9364</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P&#x02013;C(H)&#x02013;NH)&#x000b7;&#x000b7;&#x000b7;(O&#x02013;H)TYR597</td><td style="border:none;" align="char" char=".">2.3557</td><td style="border:none;" align="left">acceptor</td></tr><tr><td style="border:none;" align="left"><bold>5j</bold></td><td style="border:none;" align="char" char=".">22</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">&#x02013;7.3909</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="left">ligand(P&#x02013;C(H)&#x02013;NH)&#x000b7;&#x000b7;&#x000b7;(O&#x02013;H)TYR597</td><td style="border:none;" align="char" char=".">2.2885</td><td style="border:none;" align="left">acceptor</td></tr></tbody></table></table-wrap><p>Remarkably, they were bound to GLN340 with a binding
energy of
&#x02212;9.2938 to &#x02212;7.7212 kcal/mol with a rational bond length
of 1.9604&#x02013;2.4743 &#x000c5; in forming hydrogen bonds. Profoundly,
compounds <bold>5a&#x02013;j</bold> formed hydrogen bonding with GLN340
as an oxygen atom of the phosphoryl group has been strongly bound
to an amino hydrogen atom of the amide bond present on the glutamine;
hence, here the title compounds act as the electron cloud donors in
forming the hydrogen bond. Similarly, the binding specificity of <bold>5a&#x02013;j</bold> with chain A (containing 767 amino acids) of 4M7E
(brassinosteroid insensitive 1) protein has confirmed their plant
growth regulatory activity as they were intensely bound with tyrosine
amino acid residue (TYR597) located at the 597 position of the amino
acid series in the chain. This assures the core interaction of synthesized
compounds at central position of chain A, which is a valid consideration
to support plant growth regulatory activity. Remarkably, they were
bound to TYR597 with a binding energy of &#x02212;8.1484 to &#x02212;7.3909
kcal/mol with a rational bond length of 1.9397&#x02013;2.7589 &#x000c5;
in forming hydrogen bonds. Profoundly, compounds <bold>5a&#x02013;j</bold> formed hydrogen bonding with TYR597 as the amino hydrogen atom of
the &#x003b1;-aminophosphoryl group has been strongly bound to the phenolic
oxygen atom present on the tyrosine; hence, here the compounds <bold>5a&#x02013;j</bold> act as electron cloud acceptors in forming the
hydrogen bond. This investigation unveils that GLN340 and TYR597 amino
acids are strongly bound to <bold>5a&#x02013;j</bold> and are act as
donors and acceptors, respectively, and responsible for the predicted <italic>in vitro</italic> activities.</p></sec><sec id="sec2.5"><label>2.5</label><title>ADMET
Properties</title><p>The analysis of
ADMET profiles for a library of molecules under scrutiny helps to
figure out the physicochemical collaborations and evaluate their druglikeness
properties. This sort of high-throughput screening assists in characterizing
a lead one out of a large group in the captivated field of a target.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> This critical investigation had supported in
predicting the pharmacokinetic effects of <bold>5a&#x02013;j</bold> and to disclose the druglikeness properties. Among the ADMET properties,
the human intestinal absorption designates transporting of the effective
composites to the target cell tissues <italic>via</italic> blood stream
and sustains their mutual interaction. During this the oral administration
of a compound under study, its degree of absorption has been taken
into account, which depends on its intrinsic bioavailability characteristics.
In turnout, the absorbed quantity of the analyte is distributed to
the muscles and then to other organs in self-circulation mode through
extracellular sites. Then, the distribution of analyte drops down
its plasma concentration autonomously and then metabolized; from there,
such metabolites will be dispersed to the target sites by enzymatic
redox reactions. In pharmacological perspectives, potentially distributed
metabolites will work competently for cellular organisms, and on the
other side, the inactive metabolites deactivate the controlled entity
and moderate its possible effect <italic>in vivo</italic>; finally,
the inert metabolites are inevitably emitted by kidneys. The analysis
of the acquired ADMET profiles (<xref rid="tbl7" ref-type="other">Table <xref rid="tbl7" ref-type="other">7</xref></xref>) of <bold>5a&#x02013;j</bold> infers us about the <italic>in vivo</italic> blood&#x02013;brain barrier (BBB) penetration potentiality
ratio which is operational in the range of 0.4518&#x02013;2.5729 and
authorizes their high central nervous system (CNS) significance and
commends their greater permeability for its distribution <italic>in
vivo</italic>. It is strengthened on the source that the <italic>in
vitro</italic> Caco-2 cell permeability property is effective within
16.1225 to 21.7231 nm/s range and establishes their insistent moderate
permeability to bind with plasma proteins and to pierce into the BBB
system. The <italic>in vitro</italic> plasma protein binding (PPB)
affinity ranging from 90.6733 to 99.2126% empowers their robust binding
ability to plasma proteins. The <italic>in vitro</italic> Maden Darby
Canine kidney (MDCK) cell permeability readings ranging from 27.9760
to 191.0100 nm/s discloses them as worthy permeable. In the same way,
the human intestinal absorption (% HIA) in the range of 86.9710&#x02013;97.2754
ratio promises the interactions of <bold>5a&#x02013;j</bold> with suitable
species of the anticipating target domains. The negative sign of toxicity
properties of <bold>5a&#x02013;j</bold> assures them as safer and nontoxic
drugs. In summary, this analysis has revealed the physicochemical
interactions and druglikeness properties of <bold>5a&#x02013;j</bold>.</p><table-wrap id="tbl7" position="float"><label>Table 7</label><caption><title>ADMET Properties of <bold>5a&#x02013;j</bold></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">entry</th><th style="border:none;" align="center" char="."><italic>in
vivo</italic> BBB penetration (C.brain/C.blood)<xref rid="t7fn1" ref-type="table-fn">a</xref></th><th style="border:none;" align="center" char="."><italic>in
vitro</italic> Caco-2 cell permeability(nm/s)<xref rid="t7fn2" ref-type="table-fn">b</xref></th><th style="border:none;" align="center" char=".">human intestinal
absorption(HIA,&#x000a0;%)<xref rid="t7fn3" ref-type="table-fn">c</xref></th><th style="border:none;" align="center" char="."><italic>in
vitro</italic> MDCK cell permeability(nm/s)<xref rid="t7fn4" ref-type="table-fn">d</xref></th><th style="border:none;" align="center" char="."><italic>in
vitro</italic> plasma protein binding (%)<xref rid="t7fn5" ref-type="table-fn">e</xref></th><th style="border:none;" align="center">toxicity<xref rid="t7fn6" ref-type="table-fn">f</xref></th></tr></thead><tbody><tr><td style="border:none;" align="left"><bold>5a</bold></td><td style="border:none;" align="char" char=".">1.2749</td><td style="border:none;" align="char" char=".">21.7129</td><td style="border:none;" align="char" char=".">89.5313</td><td style="border:none;" align="char" char=".">191.0100</td><td style="border:none;" align="char" char=".">95.7056</td><td style="border:none;" align="left">negative</td></tr><tr><td style="border:none;" align="left"><bold>5b</bold></td><td style="border:none;" align="char" char=".">2.5729</td><td style="border:none;" align="char" char=".">21.7217</td><td style="border:none;" align="char" char=".">97.2754</td><td style="border:none;" align="char" char=".">79.4515</td><td style="border:none;" align="char" char=".">99.2126</td><td style="border:none;" align="left">negative</td></tr><tr><td style="border:none;" align="left"><bold>5c</bold></td><td style="border:none;" align="char" char=".">0.4368</td><td style="border:none;" align="char" char=".">21.7072</td><td style="border:none;" align="char" char=".">89.8057</td><td style="border:none;" align="char" char=".">122.3450</td><td style="border:none;" align="char" char=".">90.6733</td><td style="border:none;" align="left">negative</td></tr><tr><td style="border:none;" align="left"><bold>5d</bold></td><td style="border:none;" align="char" char=".">0.4900</td><td style="border:none;" align="char" char=".">18.8444</td><td style="border:none;" align="char" char=".">94.9217</td><td style="border:none;" align="char" char=".">27.9760</td><td style="border:none;" align="char" char=".">91.1146</td><td style="border:none;" align="left">negative</td></tr><tr><td style="border:none;" align="left"><bold>5e</bold></td><td style="border:none;" align="char" char=".">0.6212</td><td style="border:none;" align="char" char=".">21.7231</td><td style="border:none;" align="char" char=".">94.1342</td><td style="border:none;" align="char" char=".">74.8857</td><td style="border:none;" align="char" char=".">96.2773</td><td style="border:none;" align="left">negative</td></tr><tr><td style="border:none;" align="left"><bold>5f</bold></td><td style="border:none;" align="char" char=".">1.2911</td><td style="border:none;" align="char" char=".">21.4068</td><td style="border:none;" align="char" char=".">96.4950</td><td style="border:none;" align="char" char=".">38.0802</td><td style="border:none;" align="char" char=".">98.2989</td><td style="border:none;" align="left">negative</td></tr><tr><td style="border:none;" align="left"><bold>5g</bold></td><td style="border:none;" align="char" char=".">0.7318</td><td style="border:none;" align="char" char=".">21.6890</td><td style="border:none;" align="char" char=".">88.5328</td><td style="border:none;" align="char" char=".">186.4370</td><td style="border:none;" align="char" char=".">93.6175</td><td style="border:none;" align="left">negative</td></tr><tr><td style="border:none;" align="left"><bold>5h</bold></td><td style="border:none;" align="char" char=".">0.4699</td><td style="border:none;" align="char" char=".">21.7074</td><td style="border:none;" align="char" char=".">92.7086</td><td style="border:none;" align="char" char=".">87.8067</td><td style="border:none;" align="char" char=".">93.2263</td><td style="border:none;" align="left">negative</td></tr><tr><td style="border:none;" align="left"><bold>5i</bold></td><td style="border:none;" align="char" char=".">0.4518</td><td style="border:none;" align="char" char=".">21.6737</td><td style="border:none;" align="char" char=".">86.9710</td><td style="border:none;" align="char" char=".">122.9902</td><td style="border:none;" align="char" char=".">94.1828</td><td style="border:none;" align="left">negative</td></tr><tr><td style="border:none;" align="left"><bold>5j</bold></td><td style="border:none;" align="char" char=".">0.4560</td><td style="border:none;" align="char" char=".">16.1225</td><td style="border:none;" align="char" char=".">94.4193</td><td style="border:none;" align="char" char=".">29.6239</td><td style="border:none;" align="char" char=".">94.1007</td><td style="border:none;" align="left">negative</td></tr></tbody></table><table-wrap-foot><fn id="t7fn1"><label>a</label><p>BBB penetration
= [brain]/[blood].</p></fn><fn id="t7fn2"><label>b</label><p>Caco-2
cells derived from human
colon adenocarcinoma, possessing multiple drug transport pathways
through intestinal epithelium.</p></fn><fn id="t7fn3"><label>c</label><p>HIA (human intestinal absorption),
the sum of absorption and bioavailability evaluated from ratio of
excretion in urine, bile, and feces<italic>.</italic></p></fn><fn id="t7fn4"><label>d</label><p>MDCK cell system is used as a tool
for rapid permeability screening.</p></fn><fn id="t7fn5"><label>e</label><p>% of drug that binds to plasma protein.</p></fn><fn id="t7fn6"><label>f</label><p><italic>In vitro</italic> Ames test
by metabolic and nonmetabolic activated TA100 and TA1535 strains collected
from rat liver homogenate.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2.6"><label>2.6</label><title>QSAR Studies</title><p>The results obtained
from <italic>in silico</italic> molecular descriptor properties (<xref rid="tbl8" ref-type="other">Table <xref rid="tbl8" ref-type="other">8</xref></xref>) designates that
compounds <bold>5a&#x02013;j</bold> are designed to obey the properties
and their molecular weights ranging from 334.31 to 448.25 (less than
500 Da) approves the same. Similarly, they have been validated with
log <italic>P</italic> values in the range of 4.24&#x02013;0.96 (less
than 5) suggesting their good permeability through cell membranes.
Likewise in the line of Lipinski&#x02019;s rule of five, the number
of hydrogen bond donors &#x0003c;5 and acceptors &#x0003c;10 are also validated
in all molecules that were synthesized. Similarly, the molecular refractivity
ranging from 81.79 to 126.18 cm<sup>3</sup>/mol has also obeyed the
valid range, that is, 40&#x02013;130 cm<sup>3</sup>/mol.</p><table-wrap id="tbl8" position="float"><label>Table 8</label><caption><title>Molecular Descriptor Properties of <bold>5a&#x02013;j</bold><xref rid="t8fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th colspan="6" align="center" char=".">Lipinski
parameters<hr/></th><th colspan="3" align="center" char=".">Veber parameters<hr/></th><th colspan="6" align="center" char=".">other parameters<hr/></th></tr><tr><th style="border:none;" align="center">entry</th><th style="border:none;" align="center" char=".">MW</th><th style="border:none;" align="center" char=".">HB Don</th><th style="border:none;" align="center" char=".">HB Acc</th><th style="border:none;" align="center" char=".">log <italic>P</italic>(o/w)</th><th style="border:none;" align="center" char=".">MR</th><th style="border:none;" align="center" char=".">Lip. Vio.</th><th style="border:none;" align="center" char=".">TPSA</th><th style="border:none;" align="center" char=".">no. of RB</th><th style="border:none;" align="center" char=".">Veb. Vio.</th><th style="border:none;" align="center" char=".">no. of&#x000a0;H</th><th style="border:none;" align="center" char=".">V. Vol.</th><th style="border:none;" align="center" char=".">&#x003c1;</th><th style="border:none;" align="center" char="."><italic>S</italic></th><th style="border:none;" align="center" char=".">CLP</th><th style="border:none;" align="center" char=".">% ABS</th></tr></thead><tbody><tr><td style="border:none;" align="left"><bold>5a</bold></td><td style="border:none;" align="char" char=".">362.37</td><td style="border:none;" align="char" char=".">6</td><td style="border:none;" align="char" char=".">2</td><td style="border:none;" align="char" char=".">2.08</td><td style="border:none;" align="char" char=".">96.64</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">86.30</td><td style="border:none;" align="char" char=".">9</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">25</td><td style="border:none;" align="char" char=".">325.07</td><td style="border:none;" align="char" char=".">1.246</td><td style="border:none;" align="char" char=".">&#x02013;3.61</td><td style="border:none;" align="char" char=".">2.52</td><td style="border:none;" align="char" char=".">79.23</td></tr><tr><td style="border:none;" align="left"><bold>5b</bold></td><td style="border:none;" align="char" char=".">447.47</td><td style="border:none;" align="char" char=".">5</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">4.24</td><td style="border:none;" align="char" char=".">126.18</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">60.71</td><td style="border:none;" align="char" char=".">9</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">32</td><td style="border:none;" align="char" char=".">400.65</td><td style="border:none;" align="char" char=".">1.275</td><td style="border:none;" align="char" char=".">&#x02013;3.54</td><td style="border:none;" align="char" char=".">3.19</td><td style="border:none;" align="char" char=".">88.06</td></tr><tr><td style="border:none;" align="left"><bold>5c</bold></td><td style="border:none;" align="char" char=".">369.35</td><td style="border:none;" align="char" char=".">7</td><td style="border:none;" align="char" char=".">2</td><td style="border:none;" align="char" char=".">2.23</td><td style="border:none;" align="char" char=".">93.67</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">99.97</td><td style="border:none;" align="char" char=".">10</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">25</td><td style="border:none;" align="char" char=".">329.66</td><td style="border:none;" align="char" char=".">1.228</td><td style="border:none;" align="char" char=".">&#x02013;2.81</td><td style="border:none;" align="char" char=".">1.74</td><td style="border:none;" align="char" char=".">74.51</td></tr><tr><td style="border:none;" align="left"><bold>5d</bold></td><td style="border:none;" align="char" char=".">448.25</td><td style="border:none;" align="char" char=".">7</td><td style="border:none;" align="char" char=".">2</td><td style="border:none;" align="char" char=".">3.02</td><td style="border:none;" align="char" char=".">101.3</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">99.97</td><td style="border:none;" align="char" char=".">10</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">26</td><td style="border:none;" align="char" char=".">347.54</td><td style="border:none;" align="char" char=".">1.414</td><td style="border:none;" align="char" char=".">&#x02013;3.64</td><td style="border:none;" align="char" char=".">2.46</td><td style="border:none;" align="char" char=".">74.51</td></tr><tr><td style="border:none;" align="left"><bold>5e</bold></td><td style="border:none;" align="char" char=".">413.41</td><td style="border:none;" align="char" char=".">8</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">2.01</td><td style="border:none;" align="char" char=".">104.91</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">98.20</td><td style="border:none;" align="char" char=".">12</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">28</td><td style="border:none;" align="char" char=".">372.73</td><td style="border:none;" align="char" char=".">1.180</td><td style="border:none;" align="char" char=".">&#x02013;3.14</td><td style="border:none;" align="char" char=".">1.95</td><td style="border:none;" align="char" char=".">75.12</td></tr><tr><td style="border:none;" align="left"><bold>5f</bold></td><td style="border:none;" align="char" char=".">420.21</td><td style="border:none;" align="char" char=".">5</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">3.70</td><td style="border:none;" align="char" char=".">93.36</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">70.51</td><td style="border:none;" align="char" char=".">9</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">24</td><td style="border:none;" align="char" char=".">318.91</td><td style="border:none;" align="char" char=".">1.407</td><td style="border:none;" align="char" char=".">&#x02013;4.24</td><td style="border:none;" align="char" char=".">2.89</td><td style="border:none;" align="char" char=".">84.67</td></tr><tr><td style="border:none;" align="left"><bold>5g</bold></td><td style="border:none;" align="char" char=".">334.31</td><td style="border:none;" align="char" char=".">6</td><td style="border:none;" align="char" char=".">2</td><td style="border:none;" align="char" char=".">1.77</td><td style="border:none;" align="char" char=".">87.14</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">76.50</td><td style="border:none;" align="char" char=".">7</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">23</td><td style="border:none;" align="char" char=".">291.47</td><td style="border:none;" align="char" char=".">1.297</td><td style="border:none;" align="char" char=".">&#x02013;3.01</td><td style="border:none;" align="char" char=".">1.38</td><td style="border:none;" align="char" char=".">82.60</td></tr><tr><td style="border:none;" align="left"><bold>5h</bold></td><td style="border:none;" align="char" char=".">339.28</td><td style="border:none;" align="char" char=".">7</td><td style="border:none;" align="char" char=".">1</td><td style="border:none;" align="char" char=".">1.51</td><td style="border:none;" align="char" char=".">81.79</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">89.17</td><td style="border:none;" align="char" char=".">7</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">23</td><td style="border:none;" align="char" char=".">286.42</td><td style="border:none;" align="char" char=".">1.323</td><td style="border:none;" align="char" char=".">&#x02013;3.20</td><td style="border:none;" align="char" char=".">1.45</td><td style="border:none;" align="char" char=".">78.24</td></tr><tr><td style="border:none;" align="left"><bold>5i</bold></td><td style="border:none;" align="char" char=".">341.30</td><td style="border:none;" align="char" char=".">7</td><td style="border:none;" align="char" char=".">7</td><td style="border:none;" align="char" char=".">0.96</td><td style="border:none;" align="char" char=".">84.18</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">99.17</td><td style="border:none;" align="char" char=".">8</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">23</td><td style="border:none;" align="char" char=".">296.05</td><td style="border:none;" align="char" char=".">1.275</td><td style="border:none;" align="char" char=".">&#x02013;2.21</td><td style="border:none;" align="char" char=".">1.20</td><td style="border:none;" align="char" char=".">74.78</td></tr><tr><td style="border:none;" align="left"><bold>5j</bold></td><td style="border:none;" align="char" char=".">420.20</td><td style="border:none;" align="char" char=".">7</td><td style="border:none;" align="char" char=".">2</td><td style="border:none;" align="char" char=".">1.92</td><td style="border:none;" align="char" char=".">91.80</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">99.37</td><td style="border:none;" align="char" char=".">8</td><td style="border:none;" align="char" char=".">0</td><td style="border:none;" align="char" char=".">24</td><td style="border:none;" align="char" char=".">313.94</td><td style="border:none;" align="char" char=".">1.480</td><td style="border:none;" align="char" char=".">&#x02013;3.04</td><td style="border:none;" align="char" char=".">1.65</td><td style="border:none;" align="char" char=".">74.72</td></tr></tbody></table><table-wrap-foot><fn id="t8fn1"><label>a</label><p>MW: molecular weight;
HB Don: hydrogen
bond donors (<italic>n</italic> ON); HB Acc: hydrogen bond acceptors
(<italic>n</italic> OH NH); log <italic>P</italic>: log of octanol
to water partition coefficient; MR: molecular refractivity (cm<sup>3</sup>/mol); Lip. Vio.: lipinski violations; TPSA: total polar surface
area (&#x000c5;)<sup>2</sup>; no. of RB: number of rotatable bonds; Veb.
Vio.: Veber violations; no. of &#x0201c;H&#x0201d;: number of hydrophobic
atoms; V. Vol.: <italic>van der Waals</italic> volume; &#x003c1;: density
(gm/cc); <italic>S</italic>: solubility; CLP: clog <italic>P</italic>; and % ABS: % of absorption.</p></fn></table-wrap-foot></table-wrap><p>Hence, ascertained compounds <bold>5a&#x02013;j</bold> are following
the Lipinski rule of five, and all of them are significantly orally
active drugs with worthy druglikeness properties. Furthermore, the
total polar surface area is precised by the total effect of all polar
atoms such as oxygen, nitrogen, and attached hydrogens;<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> for instance, compounds <bold>5a&#x02013;j</bold> are also in the range of 60.71&#x02013;99.97 &#x000c5;<sup>2</sup>,
which are ultimately less than 140 &#x000c5;<sup>2</sup>, and are also
satisfying the Veber rule. Henceforth, compounds <bold>5a&#x02013;j</bold> are assessed as they can be easily diffused, absorbed, and transported
in the systems to which they are exposed. At this juncture, TPSA is
highly interrelated with the hydrogen bonding of a compound and is
accompanied with the transport properties of that drug across membranes
and the correlation of BBB for the intestinal crossing. Compounds
with TPSA &#x02264;160 &#x000c5;<sup>2</sup> have been identified as good
intestinal absorption compounds with BBB penetrability &#x02264;60
&#x000c5;<sup>2</sup> as BBB-penetrable and CNS-active agents.<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> TPSA for the scrutinized sequences all the offshoots
have been identified as the best intestinal absorbing ones. Similarly,
the number of rotatable bonds among all the compounds is identified
with a range of 7&#x02013;12, which is according to the Veber rule,
and eventually, they are also obeying the Veber&#x02019;s rule and
established themselves as orally administrable drugs. Furthermore,
the percentage of absorption in the range of 79.23&#x02013;88.06, density
ranging from 1.246 to 1.480 gm/cc, solubility in the range of &#x02212;2.21
to &#x02212;4.24, van der Waals volume ranging from 286.42 to 400.65
&#x000c5;<sup>3</sup>, and clog <italic>P</italic> ranging from 1.20
to 3.19 establish compounds <bold>5a&#x02013;j</bold> drug-like compounds
and are significantly safer. These properties helped a lot in considering
their physicochemical interactions against the target entities and
eventually helped in deciding the drug potentialities that are associated
by the bioactivity and toxicity risks studies.</p><p>The synthesized
molecules <bold>5a&#x02013;j</bold> are identified
with the fingerprint properties (<xref rid="tbl9" ref-type="other">Table <xref rid="tbl9" ref-type="other">9</xref></xref>) as having all of them are having the C1 point group
of symmetry elements in them and heat of formation is identified within
the range of &#x02212;96.74 to &#x02212;241.18 kcal/mol, total energy
ranges from &#x02212;3852.44 to &#x02212;5123.82 eV, electronic energy
ranges from &#x02212;26907.7 to &#x02212;40651.74 eV, and core&#x02013;core
repulsion energy ranges from 23055.26 to 35527.92 eV. Similarly, the
gradient norm is identified in the ranges of values from 0.90 to 0.99,
whereas the dipole difference is identified with 0.82&#x02013;2.49
debye. The filled levels were identified with 58&#x02013;75 units,
and the ionization potential values are identified from 8.14 to 9.17
eV. Similarly, highest occupied molecular orbital (HOMO) and lowest
unoccupied molecular orbital (LUMO) energies are identified from &#x02212;8.14
to &#x02212;9.17 eV and from &#x02212;0.6 to 0.3 eV, respectively. Similarly,
the Cosmo area and Cosmo volumes are identified within the range of
330.80&#x02013;402.91 &#x000c5;<sup>2</sup> and 375.71&#x02013;497.09 &#x000c5;<sup>3</sup>, respectively. All these predicted values confirm that the
synthesized molecules are correlating with the potential limits of
safer drugs and pharmaceuticals, and hence, in complementary perspectives
of the molecular descriptors, they are obeying the QSAR properties.</p><table-wrap id="tbl9" position="float"><label>Table 9</label><caption><title>Molecular Fingerprint Properties of <bold>5a&#x02013;j</bold><xref rid="t9fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/></colgroup><thead><tr><th style="border:none;" align="center">entry</th><th style="border:none;" align="center">point group</th><th style="border:none;" align="center" char=".">H.F. (kcal/mol)</th><th style="border:none;" align="center" char=".">T.E. (eV)</th><th style="border:none;" align="center" char=".">E.E. (eV)</th><th style="border:none;" align="center" char=".">C.C.R. (eV)</th><th style="border:none;" align="center" char=".">G.N.</th><th style="border:none;" align="center" char=".">dipole (Debye)</th><th style="border:none;" align="center" char=".">no. of F.L.</th><th style="border:none;" align="center" char=".">I.P. (eV)</th><th style="border:none;" align="center" char=".">H.E. (eV)</th><th style="border:none;" align="center" char=".">L.E. (eV)</th><th style="border:none;" align="center" char=".">C.A. (&#x000c5;<sup>2</sup>)</th><th style="border:none;" align="center" char=".">C.V. (&#x000c5;<sup>3</sup>)</th></tr></thead><tbody><tr><td style="border:none;" align="left"><bold>5a</bold></td><td style="border:none;" align="left">C1</td><td style="border:none;" align="char" char=".">&#x02013;106.66</td><td style="border:none;" align="char" char=".">&#x02013;4165.36</td><td style="border:none;" align="char" char=".">&#x02013;31020.65</td><td style="border:none;" align="char" char=".">26855.30</td><td style="border:none;" align="char" char=".">0.98</td><td style="border:none;" align="char" char=".">1.89</td><td style="border:none;" align="char" char=".">64</td><td style="border:none;" align="char" char=".">8.36</td><td style="border:none;" align="char" char=".">&#x02013;8.36</td><td style="border:none;" align="char" char=".">0.07</td><td style="border:none;" align="char" char=".">375.31</td><td style="border:none;" align="char" char=".">430.50</td></tr><tr><td style="border:none;" align="left"><bold>5b</bold></td><td style="border:none;" align="left">C1</td><td style="border:none;" align="char" char=".">&#x02013;105.79</td><td style="border:none;" align="char" char=".">&#x02013;4165.32</td><td style="border:none;" align="char" char=".">&#x02013;31142.12</td><td style="border:none;" align="char" char=".">26976.79</td><td style="border:none;" align="char" char=".">0.94</td><td style="border:none;" align="char" char=".">1.84</td><td style="border:none;" align="char" char=".">64</td><td style="border:none;" align="char" char=".">8.14</td><td style="border:none;" align="char" char=".">&#x02013;8.14</td><td style="border:none;" align="char" char=".">0.30</td><td style="border:none;" align="char" char=".">372.69</td><td style="border:none;" align="char" char=".">431.76</td></tr><tr><td style="border:none;" align="left"><bold>5c</bold></td><td style="border:none;" align="left">C1</td><td style="border:none;" align="char" char=".">&#x02013;209.24</td><td style="border:none;" align="char" char=".">&#x02013;4489.49</td><td style="border:none;" align="char" char=".">&#x02013;33075.83</td><td style="border:none;" align="char" char=".">28586.33</td><td style="border:none;" align="char" char=".">0.92</td><td style="border:none;" align="char" char=".">2.49</td><td style="border:none;" align="char" char=".">66</td><td style="border:none;" align="char" char=".">8.79</td><td style="border:none;" align="char" char=".">&#x02013;8.79</td><td style="border:none;" align="char" char=".">&#x02013;0.05</td><td style="border:none;" align="char" char=".">370.76</td><td style="border:none;" align="char" char=".">440.94</td></tr><tr><td style="border:none;" align="left"><bold>5d</bold></td><td style="border:none;" align="left">C1</td><td style="border:none;" align="char" char=".">&#x02013;209.11</td><td style="border:none;" align="char" char=".">&#x02013;4823.17</td><td style="border:none;" align="char" char=".">&#x02013;35478.33</td><td style="border:none;" align="char" char=".">30655.16</td><td style="border:none;" align="char" char=".">0.99</td><td style="border:none;" align="char" char=".">2.09</td><td style="border:none;" align="char" char=".">69</td><td style="border:none;" align="char" char=".">8.91</td><td style="border:none;" align="char" char=".">&#x02013;8.91</td><td style="border:none;" align="char" char=".">&#x02013;0.24</td><td style="border:none;" align="char" char=".">386.63</td><td style="border:none;" align="char" char=".">463.71</td></tr><tr><td style="border:none;" align="left"><bold>5e</bold></td><td style="border:none;" align="left">C1</td><td style="border:none;" align="char" char=".">&#x02013;241.18</td><td style="border:none;" align="char" char=".">&#x02013;5123.82</td><td style="border:none;" align="char" char=".">&#x02013;40651.74</td><td style="border:none;" align="char" char=".">35527.92</td><td style="border:none;" align="char" char=".">0.90</td><td style="border:none;" align="char" char=".">1.53</td><td style="border:none;" align="char" char=".">75</td><td style="border:none;" align="char" char=".">9.07</td><td style="border:none;" align="char" char=".">&#x02013;9.0</td><td style="border:none;" align="char" char=".">&#x02013;0.30</td><td style="border:none;" align="char" char=".">402.91</td><td style="border:none;" align="char" char=".">497.09</td></tr><tr><td style="border:none;" align="left"><bold>5f</bold></td><td style="border:none;" align="left">C1</td><td style="border:none;" align="char" char=".">&#x02013;167.25</td><td style="border:none;" align="char" char=".">&#x02013;4487.54</td><td style="border:none;" align="char" char=".">&#x02013;30712.54</td><td style="border:none;" align="char" char=".">26224.99</td><td style="border:none;" align="char" char=".">0.97</td><td style="border:none;" align="char" char=".">1.97</td><td style="border:none;" align="char" char=".">63</td><td style="border:none;" align="char" char=".">9.17</td><td style="border:none;" align="char" char=".">&#x02013;9.17</td><td style="border:none;" align="char" char=".">&#x02013;0.60</td><td style="border:none;" align="char" char=".">365.74</td><td style="border:none;" align="char" char=".">429.05</td></tr><tr><td style="border:none;" align="left"><bold>5g</bold></td><td style="border:none;" align="left">C1</td><td style="border:none;" align="char" char=".">&#x02013;96.74</td><td style="border:none;" align="char" char=".">&#x02013;3852.44</td><td style="border:none;" align="char" char=".">&#x02013;26907.70</td><td style="border:none;" align="char" char=".">23055.26</td><td style="border:none;" align="char" char=".">0.99</td><td style="border:none;" align="char" char=".">1.81</td><td style="border:none;" align="char" char=".">58</td><td style="border:none;" align="char" char=".">8.38</td><td style="border:none;" align="char" char=".">&#x02013;8.38</td><td style="border:none;" align="char" char=".">0.06</td><td style="border:none;" align="char" char=".">335.01</td><td style="border:none;" align="char" char=".">384.06</td></tr><tr><td style="border:none;" align="left"><bold>5h</bold></td><td style="border:none;" align="left">C1</td><td style="border:none;" align="char" char=".">&#x02013;187.95</td><td style="border:none;" align="char" char=".">&#x02013;4147.75</td><td style="border:none;" align="char" char=".">&#x02013;27663.14</td><td style="border:none;" align="char" char=".">23515.38</td><td style="border:none;" align="char" char=".">0.91</td><td style="border:none;" align="char" char=".">1.84</td><td style="border:none;" align="char" char=".">59</td><td style="border:none;" align="char" char=".">8.86</td><td style="border:none;" align="char" char=".">&#x02013;8.86</td><td style="border:none;" align="char" char=".">&#x02013;0.20</td><td style="border:none;" align="char" char=".">330.80</td><td style="border:none;" align="char" char=".">375.71</td></tr><tr><td style="border:none;" align="left"><bold>5i</bold></td><td style="border:none;" align="left">C1</td><td style="border:none;" align="char" char=".">&#x02013;202.23</td><td style="border:none;" align="char" char=".">&#x02013;4176.70</td><td style="border:none;" align="char" char=".">&#x02013;28679.19</td><td style="border:none;" align="char" char=".">24502.48</td><td style="border:none;" align="char" char=".">0.98</td><td style="border:none;" align="char" char=".">2.43</td><td style="border:none;" align="char" char=".">60</td><td style="border:none;" align="char" char=".">8.73</td><td style="border:none;" align="char" char=".">&#x02013;8.73</td><td style="border:none;" align="char" char=".">0.05</td><td style="border:none;" align="char" char=".">335.26</td><td style="border:none;" align="char" char=".">391.00</td></tr><tr><td style="border:none;" align="left"><bold>5j</bold></td><td style="border:none;" align="left">C1</td><td style="border:none;" align="char" char=".">&#x02013;199.95</td><td style="border:none;" align="char" char=".">&#x02013;4510.28</td><td style="border:none;" align="char" char=".">&#x02013;30781.31</td><td style="border:none;" align="char" char=".">26271.03</td><td style="border:none;" align="char" char=".">0.95</td><td style="border:none;" align="char" char=".">0.82</td><td style="border:none;" align="char" char=".">63</td><td style="border:none;" align="char" char=".">9.09</td><td style="border:none;" align="char" char=".">&#x02013;9.09</td><td style="border:none;" align="char" char=".">&#x02013;0.38</td><td style="border:none;" align="char" char=".">357.86</td><td style="border:none;" align="char" char=".">417.55</td></tr></tbody></table><table-wrap-foot><fn id="t9fn1"><label>a</label><p>H.F.: heat of formation;
T.E.: total
energy; E.E.: electronic energy; C.C.R: core&#x02013;core repulsion;
G.N.: gradient norm; F.L.: filled levels; I.P.: ionization potential;
H.E.: HOMO energy; L.E.: LUMO energy; C.A.: COSMO area; and C.V.:
COSMO volume.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2.7"><label>2.7</label><title>Bioactivity and Toxicity Risk Studies</title><p>The study of
bioactivity and toxicity risk properties of <bold>5a&#x02013;j</bold> (<xref rid="tbl10" ref-type="other">Table <xref rid="tbl10" ref-type="other">10</xref></xref>) inferred
the bioactivity properties such as GPCRL (GPCR ligand property), ICM
(ion channel modulator), KI (kinase inhibitor), NRL (nuclear receptor
ligand) interactions, PI (protease inhibitor) and EI (enzyme inhibitor)
interactions, and drug properties (druglikeness and drug scores),
which have ascertained them as nontoxic and potential molecules. Prediction
of these properties by Molinspiration software had comprehensively
helped to assess the cheminformatics of <bold>5a&#x02013;j</bold> by
relating with <italic>in vitro</italic> and <italic>in vivo</italic> results based on functional group similarity. The results of toxicity
risk study supporting <bold>5a&#x02013;j</bold> as safer compounds
as they are encompassed with no risks of tumorigenicity, mutagenicity,
irritant and are showing no effect on the reproductive system and
conformed their drug-like behavior. The positive magnitude of druglikeness
represents most of the fragments that are the part of commercial drug
molecules; however, many compounds signify the negative magnitudes.<sup><xref ref-type="bibr" rid="ref66">66</xref></sup> Another important factor that infers about the
association of a substance from the administering site to the blood
stream is solubility, and good solubility leads to good absorption.<sup><xref ref-type="bibr" rid="ref67">67</xref></sup> Similarly, drug score is considered as a harmonizing
parameter that wholly represents clog <italic>P</italic>, druglikeness,
log <italic>S</italic>, toxicity risks, and molecular weight and accounted
to decide the molecule&#x02019;s inclusive potential to denote a drug.
Eventually, it is identified that all the synthesized analogues <bold>5a&#x02013;j</bold> showed higher scores (<xref rid="tbl10" ref-type="other">Table <xref rid="tbl10" ref-type="other">10</xref></xref>).</p><table-wrap id="tbl10" position="float"><label>Table 10</label><caption><title>Bioactivity Scores,
Drug Properties,
and Toxicity Risks of <bold>5a&#x02013;j</bold><xref rid="t10fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th colspan="6" align="center" char=".">bioactivity<hr/></th><th colspan="2" align="center" char=".">drug properties<hr/></th><th colspan="4" align="center">toxicity risks<hr/></th></tr><tr><th style="border:none;" align="center">entry</th><th style="border:none;" align="center" char=".">GPCRL</th><th style="border:none;" align="center" char=".">ICM</th><th style="border:none;" align="center" char=".">KI</th><th style="border:none;" align="center" char=".">NRL</th><th style="border:none;" align="center" char=".">PI</th><th style="border:none;" align="center" char=".">EI</th><th style="border:none;" align="center" char=".">drug-likeness</th><th style="border:none;" align="center" char=".">drug score</th><th style="border:none;" align="center">Mut</th><th style="border:none;" align="center">Tum</th><th style="border:none;" align="center">Irrit</th><th style="border:none;" align="center">R.E.</th></tr></thead><tbody><tr><td style="border:none;" align="left"><bold>5a</bold></td><td style="border:none;" align="char" char=".">&#x02013;0.20</td><td style="border:none;" align="char" char=".">0.14</td><td style="border:none;" align="char" char=".">&#x02013;0.20</td><td style="border:none;" align="char" char=".">&#x02013;0.46</td><td style="border:none;" align="char" char=".">0.01</td><td style="border:none;" align="char" char=".">0.11</td><td style="border:none;" align="char" char=".">&#x02013;32.76</td><td style="border:none;" align="char" char=".">0.42</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td></tr><tr><td style="border:none;" align="left"><bold>5b</bold></td><td style="border:none;" align="char" char=".">&#x02013;0.24</td><td style="border:none;" align="char" char=".">0.07</td><td style="border:none;" align="char" char=".">&#x02013;0.27</td><td style="border:none;" align="char" char=".">&#x02013;0.33</td><td style="border:none;" align="char" char=".">0.02</td><td style="border:none;" align="char" char=".">0.10</td><td style="border:none;" align="char" char=".">&#x02013;34.08</td><td style="border:none;" align="char" char=".">0.08</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td></tr><tr><td style="border:none;" align="left"><bold>5c</bold></td><td style="border:none;" align="char" char=".">&#x02013;0.46</td><td style="border:none;" align="char" char=".">0.01</td><td style="border:none;" align="char" char=".">&#x02013;0.47</td><td style="border:none;" align="char" char=".">&#x02013;0.51</td><td style="border:none;" align="char" char=".">&#x02013;0.07</td><td style="border:none;" align="char" char=".">0.02</td><td style="border:none;" align="char" char=".">&#x02013;33.04</td><td style="border:none;" align="char" char=".">0.43</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td></tr><tr><td style="border:none;" align="left"><bold>5d</bold></td><td style="border:none;" align="char" char=".">&#x02013;0.64</td><td style="border:none;" align="char" char=".">&#x02013;0.12</td><td style="border:none;" align="char" char=".">&#x02013;0.56</td><td style="border:none;" align="char" char=".">&#x02013;0.68</td><td style="border:none;" align="char" char=".">&#x02013;0.23</td><td style="border:none;" align="char" char=".">&#x02013;0.11</td><td style="border:none;" align="char" char=".">&#x02013;34.72</td><td style="border:none;" align="char" char=".">0.33</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td></tr><tr><td style="border:none;" align="left"><bold>5e</bold></td><td style="border:none;" align="char" char=".">&#x02013;0.45</td><td style="border:none;" align="char" char=".">&#x02013;0.04</td><td style="border:none;" align="char" char=".">&#x02013;0.44</td><td style="border:none;" align="char" char=".">&#x02013;0.59</td><td style="border:none;" align="char" char=".">&#x02013;0.09</td><td style="border:none;" align="char" char=".">&#x02013;0.03</td><td style="border:none;" align="char" char=".">&#x02013;30.14</td><td style="border:none;" align="char" char=".">0.44</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td></tr><tr><td style="border:none;" align="left"><bold>5f</bold></td><td style="border:none;" align="char" char=".">&#x02013;0.49</td><td style="border:none;" align="char" char=".">&#x02013;0.04</td><td style="border:none;" align="char" char=".">&#x02013;0.46</td><td style="border:none;" align="char" char=".">&#x02013;0.62</td><td style="border:none;" align="char" char=".">&#x02013;0.18</td><td style="border:none;" align="char" char=".">&#x02013;0.08</td><td style="border:none;" align="char" char=".">&#x02013;38.50</td><td style="border:none;" align="char" char=".">0.34</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td></tr><tr><td style="border:none;" align="left"><bold>5g</bold></td><td style="border:none;" align="char" char=".">&#x02013;0.21</td><td style="border:none;" align="char" char=".">0.20</td><td style="border:none;" align="char" char=".">&#x02013;0.29</td><td style="border:none;" align="char" char=".">&#x02013;0.58</td><td style="border:none;" align="char" char=".">0.01</td><td style="border:none;" align="char" char=".">0.15</td><td style="border:none;" align="char" char=".">&#x02013;25.33</td><td style="border:none;" align="char" char=".">0.16</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td></tr><tr><td style="border:none;" align="left"><bold>5h</bold></td><td style="border:none;" align="char" char=".">&#x02013;0.47</td><td style="border:none;" align="char" char=".">&#x02013;0.01</td><td style="border:none;" align="char" char=".">&#x02013;0.65</td><td style="border:none;" align="char" char=".">&#x02013;0.75</td><td style="border:none;" align="char" char=".">&#x02013;0.06</td><td style="border:none;" align="char" char=".">0.10</td><td style="border:none;" align="char" char=".">&#x02013;25.97</td><td style="border:none;" align="char" char=".">0.15</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td></tr><tr><td style="border:none;" align="left"><bold>5i</bold></td><td style="border:none;" align="char" char=".">&#x02013;0.47</td><td style="border:none;" align="char" char=".">0.06</td><td style="border:none;" align="char" char=".">&#x02013;0.57</td><td style="border:none;" align="char" char=".">&#x02013;0.61</td><td style="border:none;" align="char" char=".">&#x02013;0.07</td><td style="border:none;" align="char" char=".">0.06</td><td style="border:none;" align="char" char=".">&#x02013;25.68</td><td style="border:none;" align="char" char=".">0.16</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td></tr><tr><td style="border:none;" align="left"><bold>5j</bold></td><td style="border:none;" align="char" char=".">&#x02013;0.66</td><td style="border:none;" align="char" char=".">&#x02013;0.07</td><td style="border:none;" align="char" char=".">&#x02013;0.66</td><td style="border:none;" align="char" char=".">&#x02013;0.79</td><td style="border:none;" align="char" char=".">&#x02013;0.22</td><td style="border:none;" align="char" char=".">&#x02013;0.08</td><td style="border:none;" align="char" char=".">&#x02013;27.42</td><td style="border:none;" align="char" char=".">0.14</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td><td style="border:none;" align="left">green</td></tr></tbody></table><table-wrap-foot><fn id="t10fn1"><label>a</label><p>GPCRL: G protein-coupled
receptor
ligand; ICM: ion channel modulator; KI: kinase inhibitor; NRL: nuclear
receptor ligand; PI: protease inhibitor; EI: enzyme inhibitor; Mut:
mutagenic; Tum: tumorigenic; Irrit: irritant; R.E.: reproductive effect;
green: green color indicates drug-conform behavior.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2.8"><label>2.8</label><title>Structure&#x02013;Activity
Relationship Studies</title><p>The molecular docking studies of <bold>5a&#x02013;j</bold> have
well established the structure&#x02013;activity relationship for them
as molecules were intensely bound to glutamine (GLN340) located on
chain C of 1DNU protein. Specifically, hydrogen bonding with GLN340
is identified as such the oxygen atom of the phosphoryl group has
been strongly bound to the amino hydrogen atom of the amide bond present
on the glutamine and is responsible for the antioxidant activity.</p><p>Similarly, molecules are strongly bound to tyrosine (TYR597) located
on chain A of 4ME7 protein. Specifically, hydrogen bonding with TYR597
is identified as such the amino hydrogen atom of the &#x003b1;-aminophosphoryl
group has been strongly bound to the phenolic oxygen atom present
on the tyrosine and is responsible for the antioxidant activity (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>). Moreover, the
oxidative stress comprehends the pathogenesis of neurodegenerative
diseases triggered by the excess quantity of reactive oxygen species
created <italic>in vivo</italic> by uneven biochemical disorders and
which again causes damage of neuronal cells and their death.<sup><xref ref-type="bibr" rid="ref68">68</xref>&#x02212;<xref ref-type="bibr" rid="ref71">71</xref></sup> In relation to this, the title compounds are identified as good
BBB-penetrable compounds; they can be considered as neuroprotective
antioxidants with CNS-active potentiality as the neuroprotective property
is determined with BBB penetration thresholds.</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Structure&#x02013;activity
relationship of <bold>5a&#x02013;j</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_0006" id="gr5" position="float"/></fig></sec></sec><sec id="sec3"><label>3</label><title>Conclusions</title><p>Novel &#x003b1;-furfuryl-2-alkylaminophosphonates
(<bold>5a&#x02013;j</bold>) were successfully synthesized with the
aid of SiO<sub>2</sub>&#x02013;I<sub>2</sub>, an eco-friendly catalyst.
Their antioxidant properties were
studied by DPPH and H<sub>2</sub>O<sub>2</sub> radical scavenging
assays. The plant growth regulatory activity in terms of growth of
root length and shoot length was studied and observed that compounds <bold>5e</bold>, <bold>5c</bold>, and <bold>5i</bold> were identified with
potential activity and comparable to the standards. The additional
studies such as ADMET, QSAR, molecular docking, and bioactivity and
toxicity risk have been well correlating with the results predicted <italic>in vitro</italic>. The complementary consideration of all the studies
has supported the synthesized compounds as potential antioxidants
and plant growth regulators with potential CNS-active neuroprotective
antioxidant activity.</p></sec><sec id="sec4"><label>4</label><title>Experimental Section</title><sec id="sec4.1"><label>4.1</label><title>General</title><p>Chemicals are acquired from
Sigma-Aldrich, solvents were distilled before use, and the reactions
were performed on a CATA-4R (Catalyst System) scientific microwave
instrument. Thin-layer chromatography (TLC) analysis has been performed
on silica gel-G-coated aluminum sheets as procured from Merck; the
analyte mobilities were visualized under UV light, iodine absorption,
and ninhydrin solution. <sup>1</sup>H and <sup>13</sup>C NMR and spectral
studies were performed on a Bruker 400 MHz spectrometer, and the spectra
were recorded in deuterated chloroform (CDCl<sub>3</sub>) by using
tetramethylsilane (TMS) as an internal reference standard.</p><p>Infrared
(IR) spectra were recorded on a Bruker Alpa-ECO-ATR-FTIR (attenuated
total reflection Fourier transform infrared) interferometer by using
a single reflection sampling module equipped with a zinc selenide
(ZNSe) crystal, and the readings were expressed in reciprocals of
centimeter (cm<sup>&#x02013;1</sup>). Mass spectra were recorded by
using an Agilent-MS spectrometer.</p></sec><sec id="sec4.2"><label>4.2</label><title>Chemistry</title><p>Synthesis of aminophosphonates
(<bold>5a&#x02013;j</bold>) has been achieved from the reaction of
a mixture of carbonyl derivatives (1.0 mmol), furfurylamine (1 mmol),
and diethyl/dimethyl hydrogen phosphite (1.0 mmol) by using SiO<sub>2</sub>&#x02013;I<sub>2</sub> (10 mol %) catalyst by irradiating under
microwave at 600 W and 40 &#x000b0;C for 15&#x02013;25 min. The reaction
progress was scrutinized by TLC for the completion of the reaction
and then 25 mL of ethyl acetate was added to the crude content and
filtered, followed by washing with ethyl acetate (2 &#x000d7; 10 mL).
Then, the solvent contents were evaporated by a rotary evaporation
process. The crude compound was purified, and the pure product was
collected by column chromatography and characterized by spectral and
elemental analysis.</p><sec id="sec4.2.1"><label>4.2.1</label><title>Diethyl (((Furan-2-ylmethyl)amino)(1<italic>H</italic>-indol-3-yl)methyl)phosphonate (<bold>5a</bold>)</title><p>Brown liquid, 92% yield (334.7 mg); FT-IR (ZnSe): &#x003c5;<sub>max</sub> 3215, 2977, 2924, 1444, 1432, 1213, 1019, 953, 734; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/TMS): &#x003b4; 10.08 (<italic>br
s</italic>, 1H), 7.71&#x02013;7.69(<italic>d</italic>, <italic>J</italic><sub><italic>HH</italic></sub> = 7.72 Hz, 1H), 7.38&#x02013;7.7.35
(<italic>m</italic>, 2H), 7.24 (<italic>s</italic>, 1H), 7.17&#x02013;7.08
(<italic>m</italic>, 2H), 6.29 (<italic>s</italic>, 1H), 6.09 (<italic>s</italic>, 1H), 4.46 (<italic>d</italic>, <italic>J</italic><sub><italic>HH</italic></sub> = 17.4 Hz, 1H), 4.16&#x02013;4.09 (<italic>m</italic>, 2H), 4.00&#x02013;3.95 (<italic>m</italic>, 1H), 3.89
(<italic>d</italic>, <italic>J</italic><sub><italic>HH</italic></sub> = 14.56, 1H). 3.81&#x02013;3.74 (<italic>m</italic>, 1H), 3.72&#x02013;3.68
(<italic>d</italic>, <italic>J</italic><sub><italic>HH</italic></sub> = 14.56, 1H), 3.19 (<italic>br s</italic>, 1H), 1.31&#x02013;1.27
(<italic>m</italic>, 3H), 1.09&#x02013;1.05 (<italic>m</italic>, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/TMS): &#x003b4; 153.05, 142.07,
136.49, 126.96, 124.99, 121.79, 119.20, 111.74, 110.20, 108.38, 107.83,
77.39, 76.91, 62.98, 52.10, 50.48, 16.17; HRMS (ESI) <italic>m</italic>/<italic>z</italic> calcd for C<sub>18</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>P<sup>+</sup> (M + H), 362.1395; found, 362.1392.</p></sec><sec id="sec4.2.2"><label>4.2.2</label><title>Diethyl (((Furan-2-ylmethyl)amino)(pyren-4-yl)methyl)phosphonate
(<bold>5b</bold>)</title><p>Dark brown liquid, 90% yield (402.3 mg);
FT-IR (ZnSe): &#x003c5;<sub>max</sub> 3318, 2981, 2920, 1678, 1234,
1017, 954, 730; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 8.49
(<italic>s</italic>, 1H), 8.34 (<italic>s</italic>, 1H), 8.28 (<italic>d</italic>, <italic>J</italic> = 7.2 Hz, 1H), 8.20&#x02013;8.12 (<italic>m</italic>, 3H), 8.05 (<italic>d</italic>, <italic>J</italic> = 9.2
Hz, 2H), 8.02&#x02013;7.93 (<italic>m</italic>, 1H), 7.37 (<italic>s</italic>, 1H), 7.29 (<italic>s</italic>, 1H), 6.28 (<italic>s</italic>, 1H), 5.99 (<italic>s</italic>, 1H), 5.33 (<italic>d</italic>, <italic>J</italic> = 19.6 Hz, 1H), 4.17&#x02013;4.03 (<italic>m</italic>,
2H), 3.90 (<italic>d</italic>, <italic>J</italic> = 14.0 Hz, 2H),
3.70 (<italic>dd</italic>, <italic>J</italic> = 15.5, 7.4 Hz, 1H),
3.60 (<italic>d</italic>, <italic>J</italic> = 14.7 Hz, 1H), 3.22
(<italic>s</italic>, 1H), 1.27 (t, <italic>J</italic> = 6.2 Hz, 3H),
0.99 (<italic>t</italic>, <italic>J</italic> = 6.6 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): &#x003b4; 152.80, 142.20, 131.37,
130.97, 130.67, 130.01, 128.90, 127.63, 125.51, 124.80, 124.75, 110.20,
108.12, 77.64, 77.32, 77.01, 63.78, 62.99, 43.70, 34.88, 16.50; HRMS
(ESI) <italic>m</italic>/<italic>z</italic> calcd for C<sub>26</sub>H<sub>26</sub>NO<sub>4</sub>P<sup>+</sup> (M + H), 447.1599; found,
447.1598.</p></sec><sec id="sec4.2.3"><label>4.2.3</label><title>Diethyl (((Furan-2-ylmethyl)amino)(4-hydroxy-3-methoxyphenyl)methyl)phosphonate
(<bold>5c</bold>)</title><p>Yellow liquid, 95% yield (349.8 mg), FT-IR
(ZnSe): &#x003c5;<sub>max</sub> 3184, 2980, 2920, 1514, 1211, 1021,
953, 738; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 7.34
(<italic>d</italic>, <italic>J</italic> = 1.0 Hz, 1H), 7.03 (<italic>s</italic>, 1H), 6.86 (<italic>d</italic>, <italic>J</italic> = 2.1
Hz, 2H), 6.32&#x02013;6.26 (<italic>m</italic>, 1H), 6.09 (<italic>d</italic>, <italic>J</italic> = 2.5 Hz, 1H), 4.08&#x02013;4.01 (<italic>m</italic>, 2H), 4.00&#x02013;3.92 (<italic>m</italic>, 2H), 3.88
(<italic>d</italic>, <italic>J</italic> = 3.2 Hz, 3H), 3.87&#x02013;3.83
(m, 1H), 3.82&#x02013;3.76 (m, 1H), 3.56 (<italic>d</italic>, <italic>J</italic> = 14.6 Hz, 1H), 1.27 (<italic>t</italic>, <italic>J</italic> = 7.1 Hz, 3H), 1.17 (<italic>t</italic>, <italic>J</italic> = 7.1
Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): &#x003b4; 152.84,
146.98, 145.75, 142.01, 126.34, 122.03, 114.45, 111.07, 110.09, 107.73,
77.41, 77.09, 76.77, 62.94, 59.59, 58.04, 55.95, 43.49, 16.32; HRMS
(ESI) <italic>m</italic>/<italic>z</italic> calcd for C<sub>17</sub>H<sub>24</sub>NO<sub>6</sub>P<sup>+</sup> (M + H), 369.1341; found,
362.1344.</p></sec><sec id="sec4.2.4"><label>4.2.4</label><title>Diethyl ((3-Bromo-4-hydroxy-5-methoxyphenyl)
((Furan-2 ylmethyl)amino) methyl) Phosphonate (<bold>5d</bold>)</title><p>Orange red liquid, 89% yield (398.7 mg), FT-IR (ZnSe): &#x003c5;<sub>max</sub> 3125, 2980, 1495, 1424, 1278, 1231, 1156, 1026, 728; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 9.73 (<italic>s</italic>, 1H), 7.35 (<italic>d</italic>, <italic>J</italic> = 1.3 Hz, 2H),
7.12 (<italic>d</italic>, <italic>J</italic> = 1.9 Hz, 2H), 6.99 (<italic>d</italic>, <italic>J</italic> = 1.8 Hz, 2H), 6.30 (<italic>d</italic>, <italic>J</italic> = 1.7 Hz, 2H), 6.10 (s, 2H), 4.11&#x02013;3.95
(m, 8H), 3.89 (<italic>d</italic>, <italic>J</italic> = 2.0 Hz, 10H),
3.80 (<italic>d</italic>, <italic>J</italic> = 15.0 Hz, 2H), 3.56
(<italic>d</italic>, <italic>J</italic> = 14.7 Hz, 2H), 3.04&#x02013;2.94
(m, 2H), 1.27 (<italic>t</italic>, <italic>J</italic> = 8.9 Hz, 6H),
1.21 (<italic>t</italic>, <italic>J</italic> = 8.1 Hz, 6H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): &#x003b4; 155.58, 150.54, 146.09,
145.12, 113.16, 110.89, 80.44, 80.12, 79.80, 66.34, 65.89, 62.25,
60.71, 59.43, 46.47, 19.38, 11.57; HRMS (ESI) <italic>m</italic>/<italic>z</italic> calcd for C<sub>17</sub>H<sub>23</sub>BrNO<sub>6</sub>P<sup>+</sup> (M + H), 447.0446; found, 447.0448.</p></sec><sec id="sec4.2.5"><label>4.2.5</label><title>Diethyl (((Furan-2-ylmethyl)amino)(3,4,5-trimethoxyphenyl)methyl)phosphonate
(<bold>5e</bold>)</title><p>Pale yellow liquid, 96% yield (396.6 mg);
FT-IR (ZnSe): &#x003c5;<sub>max</sub> 3216, 2991, 2933, 1524, 1221,
1037, 956, 735; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4;
7.33 (<italic>s</italic>, 2H), 6.67 (<italic>d</italic>, <italic>J</italic> = 2.2 Hz, 3H), 6.28 (<italic>d</italic>, <italic>J</italic> = 2.4
Hz, 2H), 6.09 (<italic>d</italic>, <italic>J</italic> = 3.3 Hz, 2H),
4.10&#x02013;3.95 (<italic>m</italic>, 8H), 3.95&#x02013;3.90 (<italic>m</italic>, 3H), 3.90&#x02013;3.81 (<italic>m</italic>, 20H), 3.78
(<italic>s</italic>, 2H), 1.26 (<italic>t</italic>, <italic>J</italic> = 7.1 Hz, 7H), 1.18 (<italic>t</italic>, <italic>J</italic> = 7.0
Hz, 7H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 153.19,
152.78, 142.03, 130.59, 110.10, 107.75, 105.67, 99.99, 77.43, 77.12,
76.80, 62.92, 60.81, 60.13, 58.59, 56.13, 43.50, 16.26; HRMS (ESI) <italic>m</italic>/<italic>z</italic> calcd for C<sub>19</sub>H<sub>28</sub>NO<sub>7</sub>P<sup>+</sup> (M + H), 413.1603; found, 413.1601.</p></sec><sec id="sec4.2.6"><label>4.2.6</label><title>Diethyl ((5-Bromo-2-fluorophenyl)((furan-2-ylmethyl)amino)methyl)phosphonate
(<bold>5f</bold>)</title><p>Orange red liquid, 85% yield (357.2 mg);
FT-IR (ZnSe): &#x003c5;<sub>max</sub> 3306, 2982, 1477, 1237, 1021,
958, 805, 731; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4;
7.73&#x02013;7.69 (m, 1H), 7.33 (<italic>ddt</italic>, <italic>J</italic> = 8.9, 4.5, 2.3 Hz, 1H), 7.29 (<italic>d</italic>, <italic>J</italic> = 1.7 Hz, 1H), 6.90 (<italic>t</italic>, <italic>J</italic> = 9.1
Hz, 1H), 6.22 (<italic>dd</italic>, <italic>J</italic> = 3.1, 1.9
Hz, 1H), 6.07 (<italic>d</italic>, <italic>J</italic> = 3.1 Hz, 1H),
4.38 (<italic>d</italic>, <italic>J</italic> = 20.3 Hz, 1H), 4.13&#x02013;4.04
(<italic>m</italic>, 2H), 3.98 (<italic>ddd</italic>, <italic>J</italic> = 12.6, 7.7, 5.8 Hz, 2H), 3.76 (<italic>d</italic>, <italic>J</italic> = 14.6 Hz, 1H), 3.55 (<italic>d</italic>, <italic>J</italic> = 14.6
Hz, 1H), 1.25 (<italic>t</italic>, <italic>J</italic> = 7.1 Hz, 3H),
1.16 (<italic>t</italic>, <italic>J</italic> = 7.1 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 161.38, 158.91, 152.21,
142.13, 132.26, 125.63, 117.00, 110.12, 107.91, 99.99, 77.50, 77.18,
76.86, 63.06, 51.97, 50.40, 43.97, 16.20; HRMS (ESI) <italic>m</italic>/<italic>z</italic> calcd for C<sub>16</sub>H<sub>20</sub>BrFNO<sub>4</sub>P<sup>+</sup> (M + H), 419.0297; found, 419.0296.</p></sec><sec id="sec4.2.7"><label>4.2.7</label><title>Dimethyl (((Furan-2-ylmethyl)amino)(1<italic>H</italic>-indol-3-yl)methyl)phosphonate
(<bold>5g</bold>)</title><p>Orange yellow solid, 90% yield (301 mg);
FT-IR (ZnSe): &#x003c5;<sub>max</sub> 3168, 2923, 2852, 1646, 1449,
1185, 1037, 731, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4;
9.49 (<italic>d</italic>, <italic>J</italic> = 23.7 Hz, 1H), 7.69&#x02013;7.60
(<italic>m</italic>, 1H), 7.42&#x02013;7.35 (<italic>m</italic>, 2H),
7.24&#x02013;7.10
(<italic>m</italic>, 3H), 6.38&#x02013;6.22 (<italic>m</italic>, 2H),
6.10 (<italic>d</italic>, <italic>J</italic> = 3.2 Hz, 1H), 4.47 (<italic>d</italic>, <italic>J</italic> = 17.4 Hz, 1H), 3.96 (<italic>d</italic>, <italic>J</italic> = 10.5 Hz, 1H), 3.76 (<italic>d</italic>, <italic>J</italic> = 10.5 Hz, 3H), 3.53 (<italic>d</italic>, <italic>J</italic> = 10.4 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>):
&#x003b4; 152.95, 142.04, 136.33, 126.85, 122.10, 119.71, 119.13, 118.66,
111.66, 110.15, 108.69, 107.85, 104.25, 100.00, 77.40, 77.09, 76.77,
53.46, 43.61; HRMS (ESI) <italic>m</italic>/<italic>z</italic> calcd
for C<sub>16</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub>P<sup>+</sup> (M + H), 334.1082; found, 334.1078.</p></sec><sec id="sec4.2.8"><label>4.2.8</label><title>Dimethyl
(benzo[<italic>d</italic>][1,3]dioxol-5-yl((furan-2-ylmethyl)amino)methyl)phosphonate
(<bold>5h</bold>)</title><p>Pale yellow solid, 83% yield (281.7 mg);
FT-IR (ZnSe): &#x003c5;<sub>max</sub> 3218, 2945, 1620, 1232, 1025,
820, 746; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 7.24
(<italic>d</italic>, <italic>J</italic> = 5.9 Hz, 2H), 6.85 (<italic>d</italic>, <italic>J</italic> = 1.5 Hz, 2H), 6.71 (<italic>dd</italic>, <italic>J</italic> = 20.1, 12.2 Hz, 4H), 6.14 (<italic>d</italic>, <italic>J</italic> = 1.8 Hz, 2H), 5.98 (<italic>t</italic>, <italic>J</italic> = 9.9 Hz, 2H), 5.79 (<italic>s</italic>, 4H), 4.86 (<italic>d</italic>, <italic>J</italic> = 87.0 Hz, 1H), 3.85 (<italic>d</italic>, <italic>J</italic> = 19.0 Hz, 2H), 3.58 (<italic>s</italic>, 6H),
3.47 (<italic>s</italic>, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 152.57, 147.92, 147.44, 141.99, 128.49, 122.28,
110.04, 108.62, 108.15, 107.68, 101.11, 59.08, 57.53, 53.42, 43.10;
HRMS (ESI) <italic>m</italic>/<italic>z</italic> calcd for C<sub>14</sub>H<sub>18</sub>NO<sub>6</sub>P<sup>+</sup> (M + H), 339.0872; found,
339.0874.</p></sec><sec id="sec4.2.9"><label>4.2.9</label><title>Dimethyl (((Furan-2-ylmethyl)amino)(4-hydroxy-3-methoxyphenyl)methyl)phosphonate
(<bold>5i</bold>)</title><p>Yellow solid, 93% yield (317.2 mg); FT-IR
(ZnSe): &#x003c5;<sub>max</sub> 3428, 3168, 2942, 1693, 1497, 1178,
1032, 732; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4;
7.28 (<italic>d</italic>, <italic>J</italic> = 4.6 Hz, 2H), 7.04 (<italic>s</italic>, 1H), 6.93 (<italic>s</italic>, 1H), 6.22 (<italic>d</italic>, <italic>J</italic> = 1.3 Hz, 1H), 6.04 (<italic>s</italic>, 1H),
3.90 (<italic>d</italic>, <italic>J</italic> = 18.9 Hz, 1H), 3.79
(<italic>s</italic>, 3H), 3.74 (<italic>d</italic>, <italic>J</italic> = 14.5 Hz, 2H), 3.67 (<italic>d</italic>, <italic>J</italic> = 10.6
Hz, 3H), 3.55 (<italic>d</italic>, <italic>J</italic> = 10.5 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 152.31, 147.92,
143.47, 142.14, 126.81, 124.91, 110.15, 108.57, 107.97, 58.69, 57.13,
56.35, 53.80, 53.65, 43.37; HRMS (ESI) <italic>m</italic>/<italic>z</italic> calcd for C<sub>15</sub>H<sub>20</sub>NO<sub>6</sub>P<sup>+</sup> (M + H), 341.1028; found, 341.1026.</p></sec><sec id="sec4.2.10"><label>4.2.10</label><title>Dimethyl((3-bromo-4-hydroxy-5-methoxyphenyl)((furan-2-ylmethyl)amino)methyl)phosphonate
(<bold>5j</bold>)</title><p>Orange red solid, 85% yield (357.1 mg);
FT-IR (ZnSe): &#x003c5;<sub>max</sub> 3373, 3113, 2949, 1603, 1515,
1455, 1203, 1029, 743; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): &#x003b4; 7.24 (<italic>d</italic>, <italic>J</italic> = 7.6 Hz,
1H), 6.92 (<italic>s</italic>, 1H), 6.83&#x02013;6.68 (<italic>m</italic>, 2H), 6.17 (<italic>d</italic>, <italic>J</italic> = 5.1 Hz, 1H),
6.00 (<italic>d</italic>, <italic>J</italic> = 4.9 Hz, 1H), 3.90 (dd, <italic>J</italic> = 18.6, 7.3 Hz, 1H), 3.76&#x02013;3.33 (<italic>m</italic>, 11H), <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): &#x003b4; 152.55,
147.49, 146.23, 142.02, 125.49, 121.76, 121.70, 115.01, 111.28, 110.07,
107.79, 77.72, 77.41, 77.05, 59.00, 57.45, 55.80, 53.66, 43.08; HRMS
(ESI) <italic>m</italic>/<italic>z</italic> calcd for C<sub>15</sub>H<sub>19</sub>BrNO<sub>6</sub>P<sup>+</sup> (M + H), 419.0133; found,
419.0131.</p></sec></sec><sec id="sec4.3"><label>4.3</label><title>Antioxidant Activity</title><sec id="sec4.3.1"><label>4.3.1</label><title>DPPH Radical Scavenging Activity</title><p>In practice, the electron
donation capacity or hydrogen atom donation
ability of a compound is confirmed from the bleaching ability of purple
color of methanolic DPPH solution to colorless. In this spectrophotometric
study, 1 mL of the test sample of compounds that are to be screened
for antioxidant activity with different concentrations (50, 100, and
200&#x003bc;g/mL) was prepared and added to 4 mL of 0.004% (w/v) methanolic
DPPH solutions.<sup><xref ref-type="bibr" rid="ref72">72</xref>&#x02212;<xref ref-type="bibr" rid="ref76">76</xref></sup> Then, the analytical mixture was mixed thoroughly for 1 min and
then incubated at room temperature for a period of 30 min. After completion
of incubation process, the absorbance of all the test samples was
measured at 517 nm and was referenced to ascorbic acid reference standards.
Finally, DPPH radical scavenging activity was obtained from the following
equation.<disp-formula id="ueq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_m001" position="anchor"/></disp-formula></p></sec><sec id="sec4.3.2"><label>4.3.2</label><title>H<sub>2</sub>O<sub>2</sub> Radical Scavenging
Activity</title><p>To the 1 mL test solution of different concentrations
(50, 100, and 200 &#x003bc;g/mL) of the synthesized compounds of the
study were added with 3.75 mM of deoxyribose, 1.0 mM of H<sub>2</sub>O<sub>2</sub>, 20 mM of potassium phosphate buffer (7.4 pH), 0.1
mM of FeCl<sub>3</sub>, and 0.1 mM of EDTA and incubated for a period
of 1 h at 37 &#x000b0;C temperature in a water bath. The degree of degradation
of deoxyribose was measured by adding thiobarbituric acid (1.0%) and
trichloroacetic acid (2.0%) and heating them in a water bath at 100
&#x000b0;C for a period of 20 min. Eventually, the absorbance of the
resulting test solutions was obtained spectrophotometrically at 532
nm from the following equation.<disp-formula id="ueq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_m002" position="anchor"/></disp-formula></p></sec></sec><sec id="sec4.4"><label>4.4</label><title>Plant Growth Regulatory Activity</title><p>Seeds were germinated at 25 &#x000b0;C for 48 h in 12 h light and 12
h darkness. Groups of 50 uniform well-sterilized seedlings were transferred
to 10 cm Petri dishes that are outlined with two discs of Whatman
no. 1 filter paper wetted with 2 mL of 0.001M aqueous methanol (control)
and 2 mL of solutions of the test compounds (<bold>5a&#x02013;j</bold>) at 50 and 100 ppm concentrations. The plants were grown in simultaneous
16 h light and 8 h dark conditions at 25 &#x000b1; 2 &#x000b0;C for 48 h
and the lengths of roots and stem were measured. The results are presented
as the average increase or decrease in root length and shoot length
compared with the control. Each experiment was repeated three times.</p></sec><sec id="sec4.5"><label>4.5</label><title>Molecular Docking Studies</title><p>The mechanistic
inhibition of propagating DPPH and H<sub>2</sub>O<sub>2</sub> free
radicals <italic>in vivo</italic> by title compounds <bold>5a&#x02013;j</bold> has been determined by studying the molecular docking interactions.
As such, the three-dimensional crystalline structural information
of identified proteins of the study were attained from protein data
bank (as pdb files) and reinvigorated them by removing bound water,
ligands, and other cofactors present in their vicinity. The .mol2
and .pdb database files of <bold>5a&#x02013;j</bold> ligands were produced
from ChemBioOffice software (ChemBio3D ultra 14.0 suite) and docked
them for the selected proteins on Swiss Dock software.<sup><xref ref-type="bibr" rid="ref77">77</xref></sup> The interactive docking poses were considered
and captured at energy-minimized optimization conditions with 0.100
of minimum root-mean standard deviation (RMSD) gradient and the interacting
binding postures are imagined through UCSF Chimera.<sup><xref ref-type="bibr" rid="ref78">78</xref></sup> The potential and highest binding energies originated with
proper ligand&#x02013;protein interactions of <bold>5a&#x02013;j</bold> with target protein receptors in chain C of 1DNU protein and chain
A of 4M7E protein, respectively, for the antioxidant and plant growth
regulatory activities and were accounted in macromolecular structural
atmosphere and acknowledged that compounds <bold>5a&#x02013;j</bold> as efficiently bound with the proteins considered for the study
and presented in <xref rid="tbl3" ref-type="other">Tables <xref rid="tbl3" ref-type="other">3</xref></xref>&#x02013;<xref rid="tbl6" ref-type="other">6</xref>.</p></sec><sec id="sec4.6"><label>4.6</label><title>ADMET
Properties</title><p>The ADMET properties
of synthesized compounds <bold>5a&#x02013;j</bold> have been calculated
on preADMET online server<sup><xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref80">80</xref></sup> and which assisted
us to understand their potentialities like <italic>in vivo</italic> BBB penetration, % HIA, <italic>in vitro</italic> Caco-2 cell permeability, <italic>in vitro</italic> Maden Darby Canine kidney (MDCK) cell permeability,
and <italic>in vitro</italic> PPB properties. In continuance, the
prediction of tumorigenic, mutagenic, reproductive, and irritant effects
has assisted in ascertaining the toxicity properties. The BBB is confined
with profoundly bound endothelial cells that constrain a compound&#x02019;s
ability to be conceded into the blood stream <italic>via</italic> the
directed route. The analysis of BBB penetration rate (in terms of
concentration ration, <italic>i.e.</italic>, [brain]/[blood]) supported
us to inspect the ability of an entity to penetrate over BBB, which
is dynamic in assigning CNS activity to the libraries of pharmacophoric
assets of a compound. The compounds proficient to pass <italic>via</italic> BBB are denoted as CNS active (where, BBB penetration rate &#x0003e;0.40)
and unable to pass are denoted as CNS inactive (where, BBB penetration
rate &#x0003c; 0.40). Similarly, Caco-2 (human colon adenocarcinoma based
cells) cells associates by an intestinal epithelium system in multiple
drug transport avenues such as transcellular, paracellular, and active
efflux transports. The compounds with <italic>in vitro</italic> Caco-2
cell permeability value &#x0003c;4 are assigned as poor, the permeability
in the range of 4&#x02013;70 is assigned as moderate, and permeability
value &#x0003e;70 is assigned as extremely permeable and are efficiently
transported
to biochemical and cellular processes. Moreover, the extent of PPB
influences distribution level of unbound quantity of compound in body
tissues and distributed over cellular sites of action and hence stimulates
to metabolize and excrete from systems. The % PPB <italic>in vitro</italic> classifies the compounds as strong if % PPB &#x0003e; 90% and as weak
if
% PPB &#x0003c; 90%, which eventually reflects its potentiality. Moreover,
the MDCK cell system is recognized as a sensible system to filter
out the prompt permeability of a compound and to decide its potentiality
as cellular life span is lower than the life span of Caco-2 cells
and therefore the correspondence stands high. Mostly, <italic>in vitro</italic> MDCK permeability &#x0003c;25 describes compound as poorly permeable,
permeability in the range of 25&#x02013;500 designated as sensibly
permeable, and permeability &#x0003e;500 designated as greatly permeable.
Likewise, the % HIA is deliberated as the percentage of an orally
administered drug compound into the hepatic portal vein. Generally,
it is accounted for ample bioavailability and absorption measured
based on the ratio of cumulative excretion in bile, urine, and feces.
The % HIA ranging from 0 to 20 entitles poor, 20&#x02013;70 entitles
moderate, and 70&#x02013;100 entitles good absorbance of a compound
under study. Coming to the toxicology perspectives, it is important
to consider the toxicology properties of an entity under study so
as to ignore the toxicity risks during the design itself. The negative
magnitude of toxicology for a compound is the outcome of its safer
drug property as they are reclining to carcinogenicity, mutagenicity,
and HERG (human ether-a-go-go related gene) channel inhibition and
its administration <italic>in vivo</italic> as presented in <xref rid="tbl7" ref-type="other">Table <xref rid="tbl7" ref-type="other">7</xref></xref>. This type of complementary
study ascertains a chemical entity as safer drugs.</p></sec><sec id="sec4.7"><label>4.7</label><title>QSAR Studies</title><p>Many proposed drugs
do not come to the clinical stage because of their poor ADMET liabilities,
but the worthy oral bioavailability can be realized them by right
poise amidst its partition and solubility.<sup><xref ref-type="bibr" rid="ref81">81</xref></sup> Computationally, Lipinski&#x02019;s rule of five<sup><xref ref-type="bibr" rid="ref82">82</xref></sup> is considered for screening newer molecules to testify
their potentiality as it states that (i) molecular weight &#x02264;
500 Da; (ii) octanol/water partition coefficient (log <italic>P</italic>) &#x02264; 5; (iv) number of hydrogen bond donors &#x02264; 5; and
(iii) number of hydrogen bond acceptors &#x02264; 10 and summarizes
the Lipinski parameters (molecular weight, hydrogen bond acceptors,
hydrogen bond donors, molecular refractivity, and octanol to water
partition coefficient). The drug-like properties predicted by Molinspiration<sup><xref ref-type="bibr" rid="ref83">83</xref></sup> are very sturdy and work on the summation of
fragment contributions and handling most of the organic compounds
to compute and to know the structural sensitivity in visualizing the
significant molecular properties like Veber parameters (number of
rotatable bonds and total polar surface area in addition to Lipinski
parameters) and other parameters like number of hydrophobic atoms;
van der Waals volume, density, solubility, calculated octanol to water
partition coefficient and percentage of absorption) has been considered
and all the quantitative structure&#x02013;activity relationship descriptors
were obtained and presented in <xref rid="tbl8" ref-type="other">Table <xref rid="tbl8" ref-type="other">8</xref></xref>.</p><p>In this QSAR analysis study, molecular descriptors
and fingerprints both play an important role as they are mathematical
representations of chemical entities and serves as the data analysis
methodological input sources in building QSAR models.<sup><xref ref-type="bibr" rid="ref84">84</xref>&#x02212;<xref ref-type="bibr" rid="ref86">86</xref></sup> In detail, molecular descriptors are the experimental results of
a molecule according to their theoretically derived properties, which
helps in understanding the molecular structure and biological activity
of the compounds under study from different facets.<sup><xref ref-type="bibr" rid="ref87">87</xref>&#x02212;<xref ref-type="bibr" rid="ref89">89</xref></sup> In complementary
molecular descriptors and fingerprint properties, both portray a vital
role in QSAR analysis and in turn in the drug discovery process.<sup><xref ref-type="bibr" rid="ref90">90</xref>&#x02212;<xref ref-type="bibr" rid="ref93">93</xref></sup> The fingerprint properties of <bold>5a&#x02013;j</bold> have been
predicted from the ChemDes server,<sup><xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref95">95</xref></sup> an integrated
aid for the computing the results. Here, the QSAR results were predicted
in MOPAC Cartesian format, a semiempirical molecular orbital package
to scrutinize molecular structures and is widely accepted for the
prediction of QSAR and other drug discovery studies. These computational
chemical studies were performed by modified neglect of diatomic overlap,
a semiempirical approach for calculating molecular electronic structural
quantum, which is designed on neglect of diatomic differential overlap
integral approximation process and the results are presented in <xref rid="tbl9" ref-type="other">Table <xref rid="tbl9" ref-type="other">9</xref></xref>.</p></sec><sec id="sec4.8"><label>4.8</label><title>Bioactivity and Toxicity Risk Studies</title><p>The drug-like
property profiles of compounds <bold>5a&#x02013;j</bold> have been
assessed on Molinspiration cheminformatics software tool,<sup><xref ref-type="bibr" rid="ref66">66</xref></sup><italic>viz.</italic>, v2018.10 Molinspiration
engine for property exploration and v2018.03 Molinspiration engine
for bioactivity score evaluations. This evaluation revealed the bioactivity
and nontoxic properties such as KI (kinase inhibitor), GPCR (G protein-coupled
receptor) ligand property, ICM (ion channel modulator), and NRL (nuclear
receptor ligand) interactions, and EI (enzyme inhibitor) and PI (protease
inhibitor) properties, drug-likeness, and drug scores and mutagenic,
tumorigenic, irritant, and reproductive effect of the synthesized
compounds have been evaluated and proved as safer drugs. On the other
hand, drug properties mounted with the multifarious offset of a set
of structural features and molecular properties, and its evaluation
helps to evaluate the close approximation of a molecule under investigation
with the notorious drugs. Hence, these toxicity risk profiles and
drug property parameters have predicted by the Osiris online property
explorer toolkit<sup><xref ref-type="bibr" rid="ref69">69</xref></sup> and consolidated the
properties under the head of bioactivity and toxicity risk studies
and are presented in <xref rid="tbl10" ref-type="other">Table <xref rid="tbl10" ref-type="other">10</xref></xref>. This study helped in considering the physicochemical interactions
of the synthesized compounds against the targeted domains and eventually
facilitated for determining corresponding drug properties by comparing
with the bioactivity properties and toxicity risk profile studies.</p></sec></sec></body><back><notes id="notes1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting
Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acsomega.0c05302?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsomega.0c05302</ext-link>.<list id="silist" list-type="simple"><list-item><p>Spectra of compounds <bold>5a</bold>&#x02212;<bold>j</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c05302/suppl_file/ao0c05302_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c05302_si_001.pdf"><caption><p>ao0c05302_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="COI-statement" id="NOTES-d7e6183-autogenerated"><p>The authors declare no
competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>The author M.R.N. expresses
thanks to the Department
of Science and Technology, New Delhi, India, for the financial support
under DST-INSPIRE Fellowship program no. DST/INSPIRE Fellowship/IF150757,
dated: 14/01/16. The author M.G. expresses thanks to DST-PURSE 2<sup>nd</sup> Phase Programme facilitated at Sri Venkateswara University,
Tirupati, India, by Department of Science and Technology, New Delhi,
India [17118-UGC-III(3)/DST-PURSE 2nd Phase/2017, Dt: 23-08-2018],
for funding. The authors V.K.R.A. and G.V.Z. are thankful to Ural
Federal University for support and acknowledge the financial support
of the Russian Science Foundation, Moscow, Russian Federation (RSF
grant no.: 18-13-00365). The authors also acknowledge C. Devendranath
Reddy (Retd.), Sri Venkateswara University, Tirupati, India, for the
guidance.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Naidu</surname><given-names>K. R. M.</given-names></name>; <name><surname>Rao</surname><given-names>P. V.</given-names></name>; <name><surname>Raju</surname><given-names>C. N.</given-names></name>; <name><surname>Srinivasulu</surname><given-names>K.</given-names></name>
<article-title>Synthesis
and Antioxidant Activity of Substituted-1,3,2-Diazaphosphole 1-Oxides</article-title>. <source>Arch. Pharm. Chem. Life Sci.</source>
<year>2011</year>, <volume>344</volume>, <fpage>765</fpage>&#x02013;<lpage>770</lpage>. <pub-id pub-id-type="doi">10.1002/ardp.201000280</pub-id>.</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Rao</surname><given-names>A. J.</given-names></name>; <name><surname>Rao</surname><given-names>P. V.</given-names></name>; <name><surname>Rao</surname><given-names>V. ..</given-names></name>; <name><surname>Mohan</surname><given-names>C.</given-names></name>; <name><surname>Raju</surname><given-names>C. N.</given-names></name>; <name><surname>Reddy</surname><given-names>C. S.</given-names></name>
<article-title>Microwave Assisted One-pot Synthesis of Novel &#x003b1;-Aminophosphonates
and heir Biological Activity</article-title>. <source>Bull. Korean Chem.
Soc.</source>
<year>2010</year>, <volume>31</volume>, <fpage>1863</fpage>&#x02013;<lpage>1868</lpage>. <pub-id pub-id-type="doi">10.5012/bkcs.2010.31.7.1863</pub-id>.</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Reddy</surname><given-names>S. S.</given-names></name>; <name><surname>Rao</surname><given-names>V. K.</given-names></name>; <name><surname>Krishna</surname><given-names>B. S.</given-names></name>; <name><surname>Reddy</surname><given-names>C. S.</given-names></name>; <name><surname>Rao</surname><given-names>P. V.</given-names></name>; <name><surname>Raju</surname><given-names>C. N.</given-names></name>
<article-title>Synthesis, Antimicrobial,
and Antioxidant Activity
of New &#x003b1;-Aminophosphonates</article-title>. <source>Phosphorus,
Sulfur Silicon Relat. Elem.</source>
<year>2011</year>, <volume>186</volume>, <fpage>1411</fpage>&#x02013;<lpage>1421</lpage>. <pub-id pub-id-type="doi">10.1080/10426507.2010.514682</pub-id>.</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Balam</surname><given-names>S. K.</given-names></name>; <name><surname>Krishnammagari</surname><given-names>S. K.</given-names></name>; <name><surname>Soora Harinath</surname><given-names>J.</given-names></name>; <name><surname>Sthanikam</surname><given-names>S. P.</given-names></name>; <name><surname>Chereddy</surname><given-names>S. S.</given-names></name>; <name><surname>Pasupuleti</surname><given-names>V. R.</given-names></name>; <name><surname>Yellapu</surname><given-names>N. K.</given-names></name>; <name><surname>Peddiahgari</surname><given-names>V. G. R.</given-names></name>; <name><surname>Cirandur</surname><given-names>S. R.</given-names></name>
<article-title>Synthesis of N-(3-picolyl)-based 1,3,2&#x003bb;5-benzoxazaphosphinamides
as potential 11&#x003b2;-HSD1 enzyme inhibitors</article-title>. <source>Med. Chem. Res.</source>
<year>2015</year>, <volume>24</volume>, <fpage>1119</fpage>&#x02013;<lpage>1135</lpage>. <pub-id pub-id-type="doi">10.1007/s00044-014-1194-7</pub-id>.</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Prasad</surname><given-names>S. S.</given-names></name>; <name><surname>Kumar</surname><given-names>K. S.</given-names></name>; <name><surname>Jayaprakash</surname><given-names>S. H.</given-names></name>; <name><surname>Krishna</surname><given-names>B. S.</given-names></name>; <name><surname>Sundar</surname><given-names>C. S.</given-names></name>; <name><surname>Rao</surname><given-names>P. V.</given-names></name>; <name><surname>Babu</surname><given-names>T. M.</given-names></name>; <name><surname>Rajendra</surname><given-names>W.</given-names></name>; <name><surname>Reddy</surname><given-names>C. S.</given-names></name>
<article-title>Design,
Synthesis, Antioxidant, and Anti-Breast Cancer Activities of Novel
Diethyl(alkyl/aryl/heteroarylamino)(4-(pyridin-2-yl)phenyl)methylphosphonates</article-title>. <source>Arch. Pharm. Chem. Life Sci.</source>
<year>2013</year>, <volume>346</volume>, <fpage>380</fpage>&#x02013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1002/ardp.201300032</pub-id>.</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Xu</surname><given-names>Y.</given-names></name>; <name><surname>Yan</surname><given-names>K.</given-names></name>; <name><surname>Song</surname><given-names>B.</given-names></name>; <name><surname>Xu</surname><given-names>G.</given-names></name>; <name><surname>Yang</surname><given-names>S.</given-names></name>; <name><surname>Xue</surname><given-names>W.</given-names></name>; <name><surname>Hu</surname><given-names>D.</given-names></name>; <name><surname>Lu</surname><given-names>P.</given-names></name>; <name><surname>Ouyang</surname><given-names>G.</given-names></name>; <name><surname>Jin</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>Z.</given-names></name>
<article-title>Synthesis
and Antiviral Bioactivities of &#x003b1;-Aminophosphonates Containing
Alkoxyethyl Moieties</article-title>. <source>Molecules</source>
<year>2006</year>, <volume>11</volume>, <fpage>666</fpage>&#x02013;<lpage>676</lpage>. <pub-id pub-id-type="doi">10.3390/11090666</pub-id>.<pub-id pub-id-type="pmid">17971740</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Rezaei</surname><given-names>Z.</given-names></name>; <name><surname>Firouzabadi</surname><given-names>H.</given-names></name>; <name><surname>Iranpoor</surname><given-names>N.</given-names></name>; <name><surname>Ghaderi</surname><given-names>A.</given-names></name>; <name><surname>Jafari</surname><given-names>M. R.</given-names></name>; <name><surname>Jafari</surname><given-names>A. A.</given-names></name>; <name><surname>Zare</surname><given-names>H. R.</given-names></name>
<article-title>Design and one-pot synthesis of &#x003b1;-aminophosphonates
and bis(&#x003b1;-aminophosphonates) by iron(III) chloride and cytotoxic
activity</article-title>. <source>Eur. J. Med. Chem.</source>
<year>2009</year>, <volume>44</volume>, <fpage>4266</fpage>&#x02013;<lpage>4275</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2009.07.009</pub-id>.<pub-id pub-id-type="pmid">19679380</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Vahdat</surname><given-names>S. M.</given-names></name>; <name><surname>Baharfar</surname><given-names>R.</given-names></name>; <name><surname>Tajbakhsh</surname><given-names>M.</given-names></name>; <name><surname>Heydari</surname><given-names>A.</given-names></name>; <name><surname>Baghbanian</surname><given-names>S. M.</given-names></name>; <name><surname>Khaksar</surname><given-names>S.</given-names></name>
<article-title>Organocatalytic synthesis
of &#x003b1;-hydroxy and &#x003b1;-aminophosphonates</article-title>. <source>Tetrahedron Lett.</source>
<year>2008</year>, <volume>49</volume>, <fpage>6501</fpage>&#x02013;<lpage>6504</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2008.08.094</pub-id>.</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Akbari</surname><given-names>J.</given-names></name>; <name><surname>Heydari</surname><given-names>A.</given-names></name>
<article-title>A sulfonic acid functionalized
ionic liquid as a homogeneous
and recyclable catalyst for the one-pot synthesis of &#x003b1;-aminophosphonates</article-title>. <source>Tetrahedron Lett.</source>
<year>2009</year>, <volume>50</volume>, <fpage>4236</fpage>&#x02013;<lpage>4238</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2009.05.020</pub-id>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Karimi-Jaberi</surname><given-names>Z.</given-names></name>; <name><surname>Amiri</surname><given-names>M.</given-names></name>
<article-title>One-pot synthesis of &#x003b1;-aminophosphonates catalyzed by boric
acid at room temperature</article-title>. <source>Heteroat. Chem.</source>
<year>2010</year>, <volume>21</volume>, <fpage>96</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1002/hc.20577</pub-id>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Ambica</surname><given-names>S.</given-names></name>; <name><surname>Kumar</surname><given-names>K. K.</given-names></name>; <name><surname>Taneja</surname><given-names>S. C.</given-names></name>; <name><surname>Hundal</surname><given-names>M. S.</given-names></name>; <name><surname>Kapoor</surname><given-names>K. K.</given-names></name>
<article-title>One-pot
synthesis of &#x003b1;-aminophosphonates catalyzed by antimony trichloride
adsorbed on alumina</article-title>. <source>Tetrahedron Lett.</source>
<year>2008</year>, <volume>49</volume>, <fpage>2208</fpage>&#x02013;<lpage>2212</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2008.02.047</pub-id>.</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Kafarski</surname><given-names>P.</given-names></name>; <name><surname>Lejczak</surname><given-names>B.</given-names></name>
<article-title>Biological activity
of aminophosphonic acids</article-title>. <source>Phosphorus, Sulfur
Silicon Relat. Elem.</source>
<year>1991</year>, <volume>63</volume>, <fpage>193</fpage>&#x02013;<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1080/10426509108029443</pub-id>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Smith</surname><given-names>A. B.</given-names><suffix>III</suffix></name>; <name><surname>Taylor</surname><given-names>C. M.</given-names></name>; <name><surname>Benkovic</surname><given-names>S. J.</given-names></name>; <name><surname>Hirschmann</surname><given-names>R.</given-names></name>
<article-title>Peptide bond
formation via catalytic antibodies: Synthesis of a novel phosphonate
diester hapten</article-title>. <source>Tetrahedron Lett.</source>
<year>1994</year>, <volume>35</volume>, <fpage>6853</fpage>&#x02013;<lpage>6856</lpage>. <pub-id pub-id-type="doi">10.1016/0040-4039(94)85022-4</pub-id>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Galezowska</surname><given-names>J.</given-names></name>; <name><surname>Gumienna-Kontecka</surname><given-names>E.</given-names></name>
<article-title>Phosphonates,
their complexes and bio-applications:
A spectrum of surprising diversity</article-title>. <source>Coord. Chem.
Rev.</source>
<year>2012</year>, <volume>256</volume>, <fpage>105</fpage>&#x02013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2011.07.002</pub-id>.</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Hosseini-Sarvari</surname><given-names>M.</given-names></name>
<article-title>TiO2 as a
new and reusable catalyst for one-pot three-component syntheses of
&#x003b1;-aminophosphonates in solvent-free conditions</article-title>. <source>Tetrahedron</source>
<year>2008</year>, <volume>64</volume>, <fpage>5459</fpage>&#x02013;<lpage>5466</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2008.04.016</pub-id>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Bhagat</surname><given-names>S.</given-names></name>; <name><surname>Chakraborti</surname><given-names>A. K.</given-names></name>
<article-title>An Extremely
Efficient Three-Component Reaction of
Aldehydes/Ketones, Amines, and Phosphites (Kabachnik&#x02013;Fields
Reaction) for the Synthesis of &#x003b1;-Aminophosphonates Catalyzed
by Magnesium Perchlorate</article-title>. <source>J. Org. Chem.</source>
<year>2007</year>, <volume>72</volume>, <fpage>1263</fpage>&#x02013;<lpage>1270</lpage>. <pub-id pub-id-type="doi">10.1021/jo062140i</pub-id>.<pub-id pub-id-type="pmid">17253748</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Makhaeva</surname><given-names>G. F.</given-names></name>; <name><surname>Malygin</surname><given-names>V. V.</given-names></name>; <name><surname>Aksinenko</surname><given-names>A. Y.</given-names></name>; <name><surname>Sokolov</surname><given-names>V. B.</given-names></name>; <name><surname>Strakhova</surname><given-names>N. N.</given-names></name>; <name><surname>Rasdolsky</surname><given-names>A. N.</given-names></name>; <name><surname>Richardson</surname><given-names>R. J.</given-names></name>; <name><surname>Martynov</surname><given-names>I. V.</given-names></name>
<article-title>Fluorinated &#x003b1;-aminophosphonates-a
new type of irreversible inhibitors of serine hydrolases</article-title>. <source>Dokl. Biochem. Biophys.</source>
<year>2005</year>, <volume>400</volume>, <fpage>92</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1007/s10628-005-0041-7</pub-id>.<pub-id pub-id-type="pmid">15846994</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Pan</surname><given-names>W.</given-names></name>; <name><surname>Ansiaux</surname><given-names>C.</given-names></name>; <name><surname>Vincent</surname><given-names>S. P.</given-names></name>
<article-title>Synthesis
of acyclic galactitol-
and lyxitol-aminophosphonates as inhibitors of UDP-galactopyranose
mutase</article-title>. <source>Tetrahedron Lett.</source>
<year>2007</year>, <volume>48</volume>, <fpage>4353</fpage>&#x02013;<lpage>4356</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2007.04.113</pub-id>.</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Huang</surname><given-names>j.</given-names></name>; <name><surname>Chen</surname><given-names>R.</given-names></name>
<article-title>An overview of recent advances on
the synthesis and biological activity
of ?-aminophosphonic acid derivatives</article-title>. <source>Heteroat.
Chem.</source>
<year>2000</year>, <volume>11</volume>, <fpage>480</fpage>&#x02013;<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1002/1098-1071(2000)11:7&#x0003c;480::aid-hc6&#x0003e;3.0.co;2-j</pub-id>.</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Kiran</surname><given-names>Y. B.</given-names></name>; <name><surname>Vasu Govardhana Reddy</surname><given-names>P.</given-names></name>; <name><surname>Devendranath Reddy</surname><given-names>C.</given-names></name>; <name><surname>Gunasekar</surname><given-names>D.</given-names></name>; <name><surname>Eswara Reddy</surname><given-names>N. P.</given-names></name>
<article-title>Synthesis
of [3-(3-Chloro-4-fluorophenyl)-2-oxo-3,4-dihydro-2H-2&#x003bb;5-
benzo[e][1,3,2]oxazaphosphinin-2-yl]-(aryl/alkyl) Methanols and Their
Bioactivity on Sugarcane Smut</article-title>. <source>J. Agric. Food
Chem.</source>
<year>2007</year>, <volume>55</volume>, <fpage>6933</fpage>&#x02013;<lpage>6939</lpage>. <pub-id pub-id-type="doi">10.1021/jf070850z</pub-id>.<pub-id pub-id-type="pmid">17661484</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Bhagat</surname><given-names>S.</given-names></name>; <name><surname>Chakraborti</surname><given-names>A. K.</given-names></name>
<article-title>Zirconium(IV)
Compounds As Efficient Catalysts for
Synthesis of &#x003b1;-Aminophosphonates</article-title>. <source>J. Org.
Chem.</source>
<year>2008</year>, <volume>73</volume>, <fpage>6029</fpage>&#x02013;<lpage>6032</lpage>. <pub-id pub-id-type="doi">10.1021/jo8009006</pub-id>.<pub-id pub-id-type="pmid">18576690</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Heydari</surname><given-names>A.</given-names></name>; <name><surname>Khaksar</surname><given-names>S.</given-names></name>; <name><surname>Tajbakhsh</surname><given-names>M.</given-names></name>
<article-title>Trifluoroethanol
as a metal-free,
homogeneous and recyclable medium for the efficient one-pot synthesis
of &#x003b1;-amino nitriles and &#x003b1;-amino phosphonates</article-title>. <source>Tetrahedron Lett.</source>
<year>2009</year>, <volume>50</volume>, <fpage>77</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2008.10.106</pub-id>.</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Kafarski</surname><given-names>P.</given-names></name>; <name><surname>Lejczak</surname><given-names>B.</given-names></name>; <name><surname>Slesak</surname><given-names>E.</given-names></name>; <name><surname>Przetocki</surname><given-names>J.</given-names></name>
<article-title>Plant growth
regulating activity of aromatic aminophosphonates and their short
peptides</article-title>. <source>Pestic. Sci.</source>
<year>1989</year>, <volume>25</volume>, <fpage>137</fpage>&#x02013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1002/ps.2780250205</pub-id>.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Wieczorek</surname><given-names>P.</given-names></name>; <name><surname>Miliszkiewicz</surname><given-names>D.</given-names></name>; <name><surname>Lejczak</surname><given-names>B.</given-names></name>; <name><surname>Soroka</surname><given-names>M.</given-names></name>; <name><surname>Kafarski</surname><given-names>P.</given-names></name>
<article-title>Plant-growth-regulating
N-(phosphonoacetyl)amines</article-title>. <source>Pestic. Sci.</source>
<year>1994</year>, <volume>40</volume>, <fpage>57</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1002/ps.2780400110</pub-id>.</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="book" id="cit25"><person-group person-group-type="allauthors"><name><surname>Hassall</surname><given-names>C. H.</given-names></name></person-group><article-title>Alafosfalin
(Ro 03-7008, Alaphosphin)</article-title>. In <source>Modes and mechanisms
of microbial growth inhibitors. Antibiotics</source>; <person-group person-group-type="editor"><name><surname>Hahn</surname><given-names>F. E.</given-names></name></person-group>, Ed.; <publisher-name>Springer</publisher-name>: <publisher-loc>Berlin, Heidelberg</publisher-loc>, <year>1983</year>; Vol. <volume>6</volume>; pp <fpage>1</fpage>&#x02013;<lpage>11</lpage>.</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Matveeva</surname><given-names>E. D.</given-names></name>; <name><surname>Podrugina</surname><given-names>T. A.</given-names></name>; <name><surname>Prisyazhnoi</surname><given-names>M. V.</given-names></name>; <name><surname>Rusetskaya</surname><given-names>I. N.</given-names></name>; <name><surname>Zefirov</surname><given-names>N. S.</given-names></name>
<article-title>Three-component
catalytic method for synthesis of &#x003b1;-amino
phosphonates with the use of &#x003b1;-amino acids as amine component</article-title>. <source>Russ. Chem. Bull.</source>
<year>2007</year>, <volume>56</volume>, <fpage>798</fpage>&#x02013;<lpage>805</lpage>. <pub-id pub-id-type="doi">10.1007/s11172-007-0119-8</pub-id>.</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Matveeva</surname><given-names>E. D.</given-names></name>; <name><surname>Podrugina</surname><given-names>T. A.</given-names></name>; <name><surname>Prisyajnoy</surname><given-names>M. V.</given-names></name>; <name><surname>Zefirov</surname><given-names>N. S.</given-names></name>
<article-title>Ketones in the catalytic
three-component &#x0201c;one-pot&#x0201d; Kabachnik-Fields synthesis
of &#x003b1;-amino phosphonates</article-title>. <source>Russ. Chem. Bull.</source>
<year>2006</year>, <volume>55</volume>, <fpage>1209</fpage>&#x02013;<lpage>1214</lpage>. <pub-id pub-id-type="doi">10.1007/s11172-006-0400-2</pub-id>.</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Salmeia</surname><given-names>K. A.</given-names></name>; <name><surname>Gaan</surname><given-names>S.</given-names></name>
<article-title>An overview of some
recent advances in DOPO-derivatives: Chemistry
and flame retardant applications</article-title>. <source>Polym. Degrad.
Stab.</source>
<year>2015</year>, <volume>113</volume>, <fpage>119</fpage>&#x02013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.polymdegradstab.2014.12.014</pub-id>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="book" id="cit29"><person-group person-group-type="allauthors"><name><surname>Sobkowski</surname><given-names>M.</given-names></name>; <name><surname>Kraszewski</surname><given-names>A.</given-names></name>; <name><surname>Stawinski</surname><given-names>J.</given-names></name></person-group><article-title>Recent advances
in H-phosphonate chemistry. Part 2. Synthesis of C-phosphonate derivatives</article-title>. In <source>Phosphorus chemistry II. Topics in current chemistry</source>; <person-group person-group-type="editor"><name><surname>Montchamp</surname><given-names>J. L.</given-names></name></person-group>, Ed.; <publisher-name>Springer</publisher-name>: <publisher-loc>Cham</publisher-loc>, <year>2014</year>; Vol. <volume>361</volume>; pp <fpage>179</fpage>&#x02013;<lpage>216</lpage>.</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Zhao</surname><given-names>R.</given-names></name>; <name><surname>Rupper</surname><given-names>P.</given-names></name>; <name><surname>Gaan</surname><given-names>S.</given-names></name>
<article-title>Recent development
in phosphonic
acid-based organic coatings on Aluminum</article-title>. <source>Coatings</source>
<year>2017</year>, <volume>7</volume>, <fpage>133</fpage><pub-id pub-id-type="doi">10.3390/coatings7090133</pub-id>.</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Qiu</surname><given-names>J.-J.</given-names></name>; <name><surname>Xue</surname><given-names>Q.</given-names></name>; <name><surname>Liu</surname><given-names>Y.-Y.</given-names></name>; <name><surname>Pan</surname><given-names>M.</given-names></name>; <name><surname>Liu</surname><given-names>C.-M.</given-names></name>
<article-title>A New Polymer Containing
&#x003b1;-Aminophosphonate Unit Used as Reactive, Halogen-Free Flame
Retardant for Epoxy Resins</article-title>. <source>Elem</source>
<year>2014</year>, <volume>189</volume>, <fpage>361</fpage>&#x02013;<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1080/10426507.2013.819869</pub-id>.</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="book" id="cit32"><person-group person-group-type="allauthors"><name><surname>Cr&#x000e9;py</surname><given-names>K. V. L.</given-names></name>; <name><surname>Imamoto</surname><given-names>T.</given-names></name></person-group><article-title>New
P-chirogenic phosphine ligands and their use in catalytic asymmetric
reactions</article-title>. In <source>New aspects in phosphorus chemistry
III. Topics in current chemistry</source>; <person-group person-group-type="editor"><name><surname>Majoral</surname><given-names>J.-P.</given-names></name></person-group>, Ed.; <publisher-name>Springer</publisher-name>: <publisher-loc>Berlin, Heidelberg</publisher-loc>, <year>2003</year>; Vol <volume>229</volume>; pp <fpage>27</fpage>&#x02013;<lpage>37</lpage>.</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Demchuk</surname><given-names>O. M.</given-names></name>; <name><surname>Jasi&#x00144;ski</surname><given-names>R.</given-names></name>
<article-title>Organophosphorus
ligands: Recent developments in design,
synthesis, and application in environmentally benign catalysis</article-title>. <source>Phosphorus, Sulfur Silicon Relat. Elem.</source>
<year>2016</year>, <volume>191</volume>, <fpage>245</fpage>&#x02013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1080/10426507.2015.1064921</pub-id>.</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Anusha</surname><given-names>G.</given-names></name>; <name><surname>Reddy</surname><given-names>M. V. K.</given-names></name>; <name><surname>Govardhana Reddy</surname><given-names>P. V.</given-names></name>
<article-title>SingaCycleTM-A1-catalyzed
successive
Suzuki-Miyaura and Buchwald couplings for the synthesis of various
new pyridine analogues</article-title>. <source>ChemistrySelect</source>
<year>2018</year>, <volume>3</volume>, <fpage>13182</fpage>&#x02013;<lpage>13190</lpage>. <pub-id pub-id-type="doi">10.1002/slct.201802282</pub-id>.</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Reddy</surname><given-names>S. M.</given-names></name>; <name><surname>Reddy</surname><given-names>B. N.</given-names></name>; <name><surname>Motakatla</surname><given-names>V. K. R.</given-names></name>; <name><surname>Gokanapalli</surname><given-names>A.</given-names></name>; <name><surname>Madhvesh</surname><given-names>P.</given-names></name>; <name><surname>Reddy</surname><given-names>P. V. G.</given-names></name>
<article-title>Pd-NHC catalyzed
Suzuki-Miyaura couplings
on 3-bromo-9H-pyrido[2,3-b]indole-6-sulfonamide</article-title>. <source>Synth. Commun.</source>
<year>2019</year>, <volume>49</volume>, <fpage>1987</fpage>&#x02013;<lpage>1996</lpage>. <pub-id pub-id-type="doi">10.1080/00397911.2019.1614194</pub-id>.</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Gokanapalli</surname><given-names>A.</given-names></name>; <name><surname>Motakatla</surname><given-names>V. K. R.</given-names></name>; <name><surname>Peddiahgari</surname><given-names>V. G. R.</given-names></name>
<article-title>Benzimidazole bearing Pd&#x02013;PEPPSI
complexes catalyzed direct C2-arylation/heteroarylation of N-substituted
benzimidazoles</article-title>. <source>Appl. Organomet. Chem.</source>
<year>2020</year>, <volume>34</volume>, <elocation-id>e5869</elocation-id><pub-id pub-id-type="doi">10.1002/aoc.5869</pub-id>.</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Hiratake</surname><given-names>J.</given-names></name>; <name><surname>Oda</surname><given-names>J. i.</given-names></name>
<article-title>Aminophosphonic and aminoboronic acids as key elements
of a transition state analogue inhibitor of enzymes</article-title>. <source>Biosci., Biotechnol., Biochem.</source>
<year>1997</year>, <volume>61</volume>, <fpage>211</fpage>&#x02013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.61.211</pub-id>.</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="book" id="cit38"><person-group person-group-type="allauthors"><name><surname>Jane</surname><given-names>D. E.</given-names></name></person-group><article-title>Neuroactive
aminophosphonic and aminophosphinic acid derivatives</article-title>. In <source>Aminophosphonic and aminophosphinic acids, Chemistry
and Biological activity</source>; <person-group person-group-type="editor"><name><surname>Kukhar</surname><given-names>V. P.</given-names></name>, <name><surname>Hudson</surname><given-names>H. R.</given-names></name></person-group>, Eds.; <publisher-name>Wiley</publisher-name>: <publisher-loc>Chichester, New York, U.K.</publisher-loc>, <year>2000</year>; pp <fpage>483</fpage>&#x02013;<lpage>536</lpage>.</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="book" id="cit39"><person-group person-group-type="allauthors"><name><surname>Engel</surname><given-names>R.</given-names></name>; <name><surname>Cohen</surname><given-names>J.
I.</given-names></name></person-group><article-title>Synthesis of organophosphorus
compounds from elemental phosphorus</article-title>. <source>Synthesis
of carbon-phosphorus bonds</source>, <edition>2</edition>nd ed.; <publisher-name>CRC Press</publisher-name>: <publisher-loc>Boca Raton, FL, USA</publisher-loc>, <year>2003</year>; pp <fpage>9</fpage>&#x02013;<lpage>26</lpage>.</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Lin</surname><given-names>B.</given-names></name>; <name><surname>Shi</surname><given-names>S.</given-names></name>; <name><surname>Lin</surname><given-names>R.</given-names></name>; <name><surname>Cui</surname><given-names>Y.</given-names></name>; <name><surname>Fang</surname><given-names>M.</given-names></name>; <name><surname>Tang</surname><given-names>G.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>
<article-title>Cobalt-Catalyzed Oxidative
C(sp3)-H Phosphonylation for &#x003b1;-Aminophosphonates
via C(sp3)-H/P(O)-H Coupling</article-title>. <source>J. Org. Chem.</source>
<year>2018</year>, <volume>83</volume>, <fpage>6754</fpage>&#x02013;<lpage>6761</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.8b00674</pub-id>.<pub-id pub-id-type="pmid">29786437</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Zhu</surname><given-names>Z.-Q.</given-names></name>; <name><surname>Xiao</surname><given-names>L.-J.</given-names></name>; <name><surname>Guo</surname><given-names>D.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Ji</surname><given-names>J.-J.</given-names></name>; <name><surname>Zhu</surname><given-names>X.</given-names></name>; <name><surname>Xie</surname><given-names>Z.-B.</given-names></name>; <name><surname>Le</surname><given-names>Z.-G.</given-names></name>
<article-title>Cobalt-Catalyzed
Oxidative Phosphonylation
of &#x003b1;-Amino Acid Derivatives and &#x003b1;-Amino Ketones for &#x003b1;-Aminophosphonates</article-title>. <source>J. Org. Chem.</source>
<year>2019</year>, <volume>84</volume>, <fpage>435</fpage>&#x02013;<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.8b02680</pub-id>.<pub-id pub-id-type="pmid">30540464</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Peng</surname><given-names>Y.</given-names></name>; <name><surname>Fan</surname><given-names>Y.-H.</given-names></name>; <name><surname>Li</surname><given-names>S.-Y.</given-names></name>; <name><surname>Li</surname><given-names>B.</given-names></name>; <name><surname>Xue</surname><given-names>J.</given-names></name>; <name><surname>Deng</surname><given-names>Q.-H.</given-names></name>
<article-title>Iron-Catalyzed Nitrene Transfer Reaction
of 4-Hydroxystilbenes
with Aryl Azides: Synthesis of Imines via C=C Bond Cleavage</article-title>. <source>Org. Lett.</source>
<year>2019</year>, <volume>21</volume>, <fpage>8389</fpage>&#x02013;<lpage>8394</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.9b03160</pub-id>.<pub-id pub-id-type="pmid">31588751</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Kolli</surname><given-names>M. K.</given-names></name>; <name><surname>Palani</surname><given-names>E.</given-names></name>; <name><surname>Govindasamy</surname><given-names>C.</given-names></name>; <name><surname>Katta</surname><given-names>V. R.</given-names></name>
<article-title>Highly efficient
one-pot synthesis of &#x003b1;-aminophosphonates using nanoporous AlSBA-15
catalyst in a three-component system</article-title>. <source>Res. Chem.
Intermed.</source>
<year>2020</year>, <volume>46</volume>, <fpage>1047</fpage>&#x02013;<lpage>1064</lpage>. <pub-id pub-id-type="doi">10.1007/s11164-018-3458-1</pub-id>.</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Piri</surname><given-names>T.</given-names></name>; <name><surname>Peymanfar</surname><given-names>R.</given-names></name>; <name><surname>Javanshir</surname><given-names>S.</given-names></name>; <name><surname>Amirnejat</surname><given-names>S.</given-names></name>
<article-title>Magnetic BaFe12O19/Al2O3:
An Efficient Heterogeneous Lewis Acid Catalyst for the Synthesis of
&#x003b1;-Aminophosphonates (Kabachnik-Fields Reaction)</article-title>. <source>Catal. Lett.</source>
<year>2019</year>, <volume>149</volume>, <fpage>3384</fpage>&#x02013;<lpage>3394</lpage>. <pub-id pub-id-type="doi">10.1007/s10562-019-02910-8</pub-id>.</mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Maghsoodlou</surname><given-names>M. T.</given-names></name>; <name><surname>Khorassani</surname><given-names>S. M. H.</given-names></name>; <name><surname>Hazeri</surname><given-names>N.</given-names></name>; <name><surname>Rostamizadeh</surname><given-names>M.</given-names></name>; <name><surname>Sajadikhah</surname><given-names>S. S.</given-names></name>; <name><surname>Shahkarami</surname><given-names>Z.</given-names></name>; <name><surname>Maleki</surname><given-names>N.</given-names></name>
<article-title>An efficient synthesis
of &#x003b1;-Amino phosphonates using silica sulfuric acid as a heterogeneous
catalyst</article-title>. <source>Heteroat. Chem.</source>
<year>2009</year>, <volume>20</volume>, <fpage>316</fpage>&#x02013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1002/hc.20543</pub-id>.</mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Matveeva</surname><given-names>E. D.</given-names></name>; <name><surname>Podrugina</surname><given-names>T. A.</given-names></name>; <name><surname>Kolesnikova</surname><given-names>I. N.</given-names></name>; <name><surname>Zefirov</surname><given-names>N. S.</given-names></name>
<article-title>Benzoylhydrazones
in catalytic hydrophosphorylation</article-title>. <source>Russ. Chem.
Bull.</source>
<year>2010</year>, <volume>59</volume>, <fpage>411</fpage>&#x02013;<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1007/s11172-010-0094-3</pub-id>.</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Zhou</surname><given-names>K.</given-names></name>; <name><surname>Shu</surname><given-names>H.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Lou</surname><given-names>J.</given-names></name>; <name><surname>Guo</surname><given-names>D.</given-names></name>; <name><surname>Wei</surname><given-names>Z.</given-names></name>; <name><surname>Li</surname><given-names>W.</given-names></name>
<article-title>Switchable
synthesis of furfurylamine
and tetrahydrofurfurylamine from furfuryl alcohol over RANEY&#x000ae;
Nickel</article-title>. <source>Catal. Sci. Technol.</source>
<year>2017</year>, <volume>7</volume>, <fpage>4129</fpage>&#x02013;<lpage>4135</lpage>. <pub-id pub-id-type="doi">10.1039/C7CY00981J</pub-id>.</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Nishimura</surname><given-names>S.</given-names></name>; <name><surname>Mizuhori</surname><given-names>K.</given-names></name>; <name><surname>Ebitani</surname><given-names>K.</given-names></name>
<article-title>Reductive amination of furfural toward
furfurylamine with aqueous ammonia under hydrogen over Ru-supported
catalyst</article-title>. <source>Res. Chem. Intermed.</source>
<year>2016</year>, <volume>42</volume>, <fpage>19</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1007/s11164-015-2334-5</pub-id>.</mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Chatterjee</surname><given-names>M.</given-names></name>; <name><surname>Ishizaka</surname><given-names>T.</given-names></name>; <name><surname>Kawanami</surname><given-names>H.</given-names></name>
<article-title>Reductive amination
of furfural to
furfurylamine using aqueous ammonia solution and molecular hydrogen:
An environmentally friendly approach</article-title>. <source>Green
Chem.</source>
<year>2016</year>, <volume>18</volume>, <fpage>487</fpage>&#x02013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1039/C5GC01352F</pub-id>.</mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Dunbabin</surname><given-names>A.</given-names></name>; <name><surname>Subrizi</surname><given-names>F.</given-names></name>; <name><surname>Ward</surname><given-names>J. M.</given-names></name>; <name><surname>Sheppard</surname><given-names>T. D.</given-names></name>; <name><surname>Hailes</surname><given-names>H. C.</given-names></name>
<article-title>Furfurylamines
from biomass: Transaminase catalysed upgrading of furfurals</article-title>. <source>Green Chem.</source>
<year>2017</year>, <volume>19</volume>, <fpage>397</fpage>&#x02013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1039/C6GC02241C</pub-id>.</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Nikolov</surname><given-names>P. Y.</given-names></name>; <name><surname>Yaylayan</surname><given-names>V. A.</given-names></name>
<article-title>Role of the ribose-specific
marker furfuryl-amine in
the formation of aroma active 1-(furan-2-ylmethyl)-1h-pyrrole (or
furfuryl-pyrrole) derivatives</article-title>. <source>J. Agric. Food
Chem.</source>
<year>2012</year>, <volume>60</volume>, <fpage>10155</fpage>&#x02013;<lpage>10161</lpage>. <pub-id pub-id-type="doi">10.1021/jf3030002</pub-id>.<pub-id pub-id-type="pmid">22994507</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Subba
Rao</surname><given-names>D.</given-names></name>; <name><surname>Rasheed</surname><given-names>S.</given-names></name>; <name><surname>Thaslim Basha</surname><given-names>S. K.</given-names></name>; <name><surname>Naga Raju</surname><given-names>C.</given-names></name>; <name><surname>Naresh</surname><given-names>K.</given-names></name>
<article-title>SiO2/ZnCl2 catalyzed &#x003b1;-aminophosphonates and
phosphonated N-(substituted phenyl) sulfonamides of 2-aminothiophene:
Synthesis and biological evaluation</article-title>. <source>Der Pharma
Chem.</source>
<year>2013</year>, <volume>5</volume>, <fpage>61</fpage>&#x02013;<lpage>74</lpage>.</mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Keivanloo</surname><given-names>A.</given-names></name>; <name><surname>Bakherad</surname><given-names>M.</given-names></name>; <name><surname>Bahramian</surname><given-names>B.</given-names></name>; <name><surname>Baratnia</surname><given-names>S.</given-names></name>
<article-title>Silica-supported zinc
bromide (ZnBr2/SiO2): a highly efficient heterogeneous catalyst for
coupling acid chlorides with terminal alkynes</article-title>. <source>Tetrahedron Lett.</source>
<year>2011</year>, <volume>52</volume>, <fpage>1498</fpage>&#x02013;<lpage>1502</lpage>. <pub-id pub-id-type="doi">10.1016/j.tetlet.2011.01.101</pub-id>.</mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Fan</surname><given-names>G.</given-names></name>; <name><surname>Luo</surname><given-names>S.</given-names></name>; <name><surname>Wu</surname><given-names>Q.</given-names></name>; <name><surname>Fang</surname><given-names>T.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Song</surname><given-names>G.</given-names></name>
<article-title>ZnBr2 supported
on silica-coated magnetic nanoparticles of Fe3O4 for conversion of
CO2 to diphenyl carbonate</article-title>. <source>RSC Adv.</source>
<year>2015</year>, <volume>5</volume>, <fpage>56478</fpage>&#x02013;<lpage>56485</lpage>. <pub-id pub-id-type="doi">10.1039/C5RA07431B</pub-id>.</mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Ak</surname><given-names>T.</given-names></name>; <name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name>
<article-title>Antioxidant and radical scavenging
properties of curcumin</article-title>. <source>Chem.-Biol. Interact.</source>
<year>2008</year>, <volume>174</volume>, <fpage>27</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2008.05.003</pub-id>.<pub-id pub-id-type="pmid">18547552</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name>
<article-title>Antioxidant
activity of food constituents: An overview</article-title>. <source>Arch. Toxicol.</source>
<year>2012</year>, <volume>86</volume>, <fpage>345</fpage>&#x02013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1007/s00204-011-0774-2</pub-id>.<pub-id pub-id-type="pmid">22102161</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Taslimi</surname><given-names>P.</given-names></name>; <name><surname>Gul&#x000e7;in</surname><given-names>&#x00130;.</given-names></name>
<article-title>Antioxidant
and anticholinergic properties of olivetol</article-title>. <source>J. Food Biochem.</source>
<year>2018</year>, <volume>42</volume>, <elocation-id>e12516</elocation-id><pub-id pub-id-type="doi">10.1111/jfbc.12516</pub-id>.</mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Gulcin</surname><given-names>&#x00130;.</given-names></name>
<article-title>Antioxidants
and antioxidant methods: An updated overview</article-title>. <source>Arch. Toxicol.</source>
<year>2020</year>, <volume>94</volume>, <fpage>651</fpage>&#x02013;<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1007/s00204-020-02689-3</pub-id>.<pub-id pub-id-type="pmid">32180036</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Duan</surname><given-names>X.</given-names></name>; <name><surname>Wu</surname><given-names>G.</given-names></name>; <name><surname>Jiang</surname><given-names>Y.</given-names></name>
<article-title>Evaluation
of the Antioxidant Properties of Litchi
Fruit Phenolics in Relation to Pericarp Browning Prevention</article-title>. <source>Molecules</source>
<year>2007</year>, <volume>12</volume>, <fpage>759</fpage>&#x02013;<lpage>771</lpage>. <pub-id pub-id-type="doi">10.3390/12040759</pub-id>.<pub-id pub-id-type="pmid">17851428</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Halliwell</surname><given-names>B.</given-names></name>
<article-title>Free radicals,
antioxidants, and human disease: curiosity, cause, or consequence?</article-title>. <source>Lancet</source>
<year>1994</year>, <volume>344</volume>, <fpage>721</fpage>&#x02013;<lpage>724</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(94)92211-X</pub-id>.<pub-id pub-id-type="pmid">7915779</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Hanson</surname><given-names>J. E.</given-names></name>; <name><surname>Kaplan</surname><given-names>A. P.</given-names></name>; <name><surname>Bartlett</surname><given-names>P. A.</given-names></name>
<article-title>Phosphonate
analogs of carboxypeptidase
A substrates are potent transition-state analog inhibitors</article-title>. <source>Biochemistry</source>
<year>1989</year>, <volume>28</volume>, <fpage>6294</fpage>&#x02013;<lpage>6305</lpage>. <pub-id pub-id-type="doi">10.1021/bi00441a022</pub-id>.<pub-id pub-id-type="pmid">2790000</pub-id></mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>Smith</surname><given-names>I. K.</given-names></name>; <name><surname>Fowden</surname><given-names>L.</given-names></name>
<article-title>A Study of Mimosine
Toxicity in Plants</article-title>. <source>J. Exp. Bot.</source>
<year>1966</year>, <volume>17</volume>, <fpage>750</fpage>&#x02013;<lpage>761</lpage>. <pub-id pub-id-type="doi">10.1093/jxb/17.4.750</pub-id>.</mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name><surname>Opera</surname><given-names>T. I.</given-names></name>; <name><surname>Matter</surname><given-names>H.</given-names></name>
<article-title>Integrating virtual screening in lead discovery</article-title>. <source>Curr. Opin. Chem. Biol.</source>
<year>2004</year>, <volume>8</volume>, <fpage>349</fpage>&#x02013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2004.06.008</pub-id>.<pub-id pub-id-type="pmid">15288243</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name><surname>Ertl</surname><given-names>P.</given-names></name>; <name><surname>Rohde</surname><given-names>B.</given-names></name>; <name><surname>Selzer</surname><given-names>P.</given-names></name>
<article-title>Fast calculation
of molecular polar
surface area as a sum of fragment-based contributions and its application
to the prediction of drug transport properties</article-title>. <source>J. Med. Chem.</source>
<year>2000</year>, <volume>43</volume>, <fpage>3714</fpage>&#x02013;<lpage>3717</lpage>. <pub-id pub-id-type="doi">10.1021/jm000942e</pub-id>.<pub-id pub-id-type="pmid">11020286</pub-id></mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name><surname>da
Silva</surname><given-names>M. M.</given-names></name>; <name><surname>Comin</surname><given-names>M.</given-names></name>; <name><surname>Duarte</surname><given-names>T. S.</given-names></name>; <name><surname>Foglio</surname><given-names>M. A.</given-names></name>; <name><surname>de Carvalho</surname><given-names>J. E.</given-names></name>; <name><surname>do Vieira</surname><given-names>M. C.</given-names></name>; <name><surname>Formagio</surname><given-names>A. S. N.</given-names></name>
<article-title>Synthesis, antiproliferative
activity and molecular properties predictions of galloyl derivatives</article-title>. <source>Molecules</source>
<year>2015</year>, <volume>20</volume>, <fpage>5360</fpage>&#x02013;<lpage>5373</lpage>. <pub-id pub-id-type="doi">10.3390/molecules20045360</pub-id>.<pub-id pub-id-type="pmid">25816079</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="weblink" id="cit66"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.organic-chemistry.org/prog/peo/druglikeness.html">https://www.organic-chemistry.org/prog/peo/druglikeness.html</uri> (accessed on October 17, 2020).</mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name><surname>Alafeefy</surname><given-names>A. M.</given-names></name>; <name><surname>Alqasoumi</surname><given-names>S. I.</given-names></name>; <name><surname>Ashour</surname><given-names>A. E.</given-names></name>; <name><surname>Masand</surname><given-names>V.</given-names></name>; <name><surname>Al-Jaber</surname><given-names>N. A.</given-names></name>; <name><surname>Hadda</surname><given-names>T. B.</given-names></name>; <name><surname>Mohamed</surname><given-names>M. A.</given-names></name>
<article-title>Quinazoline-tyrphostin as a new class
of antitumor agents, molecular properties prediction, synthesis and
biological testing</article-title>. <source>Eur. J. Med. Chem.</source>
<year>2012</year>, <volume>53</volume>, <fpage>133</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2012.03.044</pub-id>.<pub-id pub-id-type="pmid">22520152</pub-id></mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name><surname>K&#x000f6;se</surname><given-names>L. P.</given-names></name>; <name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name>; <name><surname>G&#x000f6;ren</surname><given-names>A. C.</given-names></name>; <name><surname>Namiesnik</surname><given-names>J.</given-names></name>; <name><surname>Martinez-Ayala</surname><given-names>A. L.</given-names></name>; <name><surname>Gorinstein</surname><given-names>S.</given-names></name>
<article-title>LC-MS/MS analysis,
antioxidant and anticholinergic properties of galanga (Alpinia officinarum
Hance) rhizomes</article-title>. <source>Ind. Crops Prod.</source>
<year>2015</year>, <volume>74</volume>, <fpage>712</fpage>&#x02013;<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1016/j.indcrop.2015.05.034</pub-id>.</mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name><surname>Bursal</surname><given-names>E.</given-names></name>; <name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name>
<article-title>Polyphenol contents
and in vitro
antioxidant activities of lyophilised aqueous extract of kiwifruit
(Actinidia deliciosa)</article-title>. <source>Food Res. Int.</source>
<year>2011</year>, <volume>44</volume>, <fpage>1482</fpage>&#x02013;<lpage>1489</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2011.03.031</pub-id>.</mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name>; <name><surname>Bursal</surname><given-names>E.</given-names></name>; <name><surname>&#x0015e;ehito&#x0011f;lu</surname><given-names>M. H.</given-names></name>; <name><surname>Bilsel</surname><given-names>M.</given-names></name>; <name><surname>G&#x000f6;ren</surname><given-names>A. C.</given-names></name>
<article-title>Polyphenol
contents and antioxidant activity of lyophilized
aqueous extract of propolis from Erzurum, Turkey</article-title>. <source>Food Chem. Toxicol.</source>
<year>2010</year>, <volume>48</volume>, <fpage>2227</fpage>&#x02013;<lpage>2238</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2010.05.053</pub-id>.<pub-id pub-id-type="pmid">20685228</pub-id></mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal" id="cit71"><name><surname>&#x000d6;zta&#x0015f;k&#x00131;n</surname><given-names>N.</given-names></name>; <name><surname>&#x000c7;etinkaya</surname><given-names>Y.</given-names></name>; <name><surname>Taslimi</surname><given-names>P.</given-names></name>; <name><surname>G&#x000f6;ksu</surname><given-names>S.</given-names></name>; <name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name>
<article-title>Antioxidant and acetylcholinesterase
inhibition properties of novel bromophenol derivatives</article-title>. <source>Bioorg. Chem.</source>
<year>2015</year>, <volume>60</volume>, <fpage>49</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2015.04.006</pub-id>.<pub-id pub-id-type="pmid">25956827</pub-id></mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal" id="cit72"><name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name>
<article-title>Antioxidant
activity of l-adrenaline: A structure-activity insight</article-title>. <source>Chem.-Biol. Interact.</source>
<year>2009</year>, <volume>179</volume>, <fpage>71</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2008.09.023</pub-id>.<pub-id pub-id-type="pmid">18929549</pub-id></mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal" id="cit73"><name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name>
<article-title>Antioxidant
properties of resveratrol: A structure-activity insight</article-title>. <source>Innovative Food Sci. Emerging Technol.</source>
<year>2010</year>, <volume>11</volume>, <fpage>210</fpage>&#x02013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.ifset.2009.07.002</pub-id>.</mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal" id="cit74"><name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name>
<article-title>Antioxidant
activity of Eugenol: A structure-activity relationship study</article-title>. <source>J. Med. Food</source>
<year>2011</year>, <volume>14</volume>, <fpage>975</fpage>&#x02013;<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1089/jmf.2010.0197</pub-id>.<pub-id pub-id-type="pmid">21554120</pub-id></mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal" id="cit75"><name><surname>Bursal</surname><given-names>E.</given-names></name>; <name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name>
<article-title>Polyphenol
contents and in vitro
antioxidant activities of lyophilised aqueous extract of kiwifruit
(Actinidia deliciosa)</article-title>. <source>Food Res. Int.</source>
<year>2011</year>, <volume>44</volume>, <fpage>1482</fpage>&#x02013;<lpage>1489</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2011.03.031</pub-id>.</mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal" id="cit76"><name><surname>K&#x000f6;se</surname><given-names>L. P.</given-names></name>; <name><surname>G&#x000fc;l&#x000e7;ina</surname><given-names>&#x00130;.</given-names></name>; <name><surname>G&#x000f6;ren</surname><given-names>A. C.</given-names></name>; <name><surname>Namiesnik</surname><given-names>J.</given-names></name>; <name><surname>Martinez-Ayala</surname><given-names>A. L.</given-names></name>; <name><surname>Gorinstein</surname><given-names>S.</given-names></name>
<article-title>LC-MS/MS analysis,
antioxidant and anticholinergic properties of galanga (Alpinia officinarum
Hance) rhizomes</article-title>. <source>Ind. Crops Prod.</source>
<year>2015</year>, <volume>74</volume>, <fpage>712</fpage>&#x02013;<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1016/j.indcrop.2015.05.034</pub-id>.</mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="weblink" id="cit77"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.swissdock.ch/docking">http://www.swissdock.ch/docking</uri> (accessed on September 23, 2020).</mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal" id="cit78"><name><surname>Pettersen</surname><given-names>E. F.</given-names></name>; <name><surname>Thomas</surname><given-names>D. G.</given-names></name>; <name><surname>Conrad</surname><given-names>C. H.</given-names></name>; <name><surname>Gregory</surname><given-names>S. C.</given-names></name>; <name><surname>Daniel</surname><given-names>M. G.</given-names></name>; <name><surname>Elaine</surname><given-names>C. M.</given-names></name>; <name><surname>Thomas</surname><given-names>E. F.</given-names></name>
<article-title>UCSF Chimeraea visualization system
for exploratory research and analysis</article-title>. <source>J. Comput.
Chem.</source>
<year>2004</year>, <volume>25</volume>, <fpage>1605</fpage>&#x02013;<lpage>1612</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id>.<pub-id pub-id-type="pmid">15264254</pub-id></mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="journal" id="cit79"><name><surname>Bakht</surname><given-names>M. A.</given-names></name>; <name><surname>Shahar</surname><given-names>M. Y.</given-names></name>; <name><surname>Sami</surname><given-names>G. A. H.</given-names></name>; <name><surname>Saleh</surname><given-names>I. A. Q.</given-names></name>; <name><surname>Abdul</surname><given-names>S.</given-names></name>
<article-title>Molecular
properties prediction, synthesis and antimicrobial activity of some
newer oxadiazole derivatives</article-title>. <source>Eur. J. Med. Chem.</source>
<year>2010</year>, <volume>45</volume>, <fpage>5862</fpage>&#x02013;<lpage>5869</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2010.07.069</pub-id>.<pub-id pub-id-type="pmid">20965619</pub-id></mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="weblink" id="cit80"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://preadmet.bmdrc.org/">http://preadmet.bmdrc.org/</uri> (accessed on October 11, 2020).</mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="journal" id="cit81"><name><surname>Muratov</surname><given-names>E. N.</given-names></name>; <name><surname>J&#x000fc;rgen</surname><given-names>B.</given-names></name>; <name><surname>Robert</surname><given-names>P. S.</given-names></name>; <name><surname>Igor</surname><given-names>V. T.</given-names></name>; <name><surname>Dmitry</surname><given-names>F.</given-names></name>; <name><surname>Vladimir</surname><given-names>P.</given-names></name>; <name><surname>Tudor</surname><given-names>I. O.</given-names></name>; <name><surname>Igor</surname><given-names>I. B.</given-names></name>; <name><surname>Alexandre</surname><given-names>V.</given-names></name>; <name><surname>Adrian</surname><given-names>R.</given-names></name>; <name><surname>Olexandr</surname><given-names>I.</given-names></name>; <name><surname>Stefano</surname><given-names>C.</given-names></name>; <name><surname>Denis</surname><given-names>F.</given-names></name>; <name><surname>Yoram</surname><given-names>C.</given-names></name>; <name><surname>Alan</surname><given-names>A. G.</given-names></name>; <name><surname>David</surname><given-names>A. W.</given-names></name>; <name><surname>Dimitris</surname><given-names>A.</given-names></name>; <name><surname>Artem</surname><given-names>C.</given-names></name>; <name><surname>Alexander</surname><given-names>T.</given-names></name>
<article-title>QSAR without borders</article-title>. <source>Chem. Soc. Rev.</source>
<year>2020</year>, <volume>49</volume>, <fpage>3525</fpage>&#x02013;<lpage>3564</lpage>. <pub-id pub-id-type="doi">10.1039/D0CS00098A</pub-id>.<pub-id pub-id-type="pmid">32356548</pub-id></mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal" id="cit82"><name><surname>Lipinski</surname><given-names>C.
A.</given-names></name>; <name><surname>Franco</surname><given-names>L.</given-names></name>; <name><surname>Beryl</surname><given-names>W. D.</given-names></name>; <name><surname>Paul</surname><given-names>J. F.</given-names></name>
<article-title>Experimental and
computational approaches to estimate solubility and permeability in
drug discovery and development settings</article-title>. <source>Adv.
Drug Delivery Rev.</source>
<year>2001</year>, <volume>46</volume>, <fpage>3</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/S0169-409X(00)00129-0</pub-id>.</mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="weblink" id="cit83"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.molinspiration.com/cgi-bin/properties">http://www.molinspiration.com/cgi-bin/properties</uri> (accessed
on October 16, 2020).</mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal" id="cit84"><name><surname>Stumpfe</surname><given-names>D.</given-names></name>; <name><surname>Dimova</surname><given-names>D.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name>
<article-title>Computational
method for the systematic
identification of analog series and key compounds representing series
and their biological activity profiles</article-title>. <source>J. Med.
Chem.</source>
<year>2016</year>, <volume>59</volume>, <fpage>7667</fpage>&#x02013;<lpage>7676</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.6b00906</pub-id>.<pub-id pub-id-type="pmid">27501131</pub-id></mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal" id="cit85"><name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Stumpfe</surname><given-names>D.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name>
<article-title>Lessons learned
from molecular scaffold
analysis</article-title>. <source>J. Chem. Inf. Model.</source>
<year>2011</year>, <volume>51</volume>, <fpage>1742</fpage>&#x02013;<lpage>1753</lpage>. <pub-id pub-id-type="doi">10.1021/ci200179y</pub-id>.<pub-id pub-id-type="pmid">21755989</pub-id></mixed-citation></ref><ref id="ref86"><mixed-citation publication-type="journal" id="cit86"><name><surname>Gupta-Ostermann</surname><given-names>D.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name>
<article-title>The &#x02018;SAR Matrix&#x02019; method and its extensions
for applications in medicinal chemistry and chemogenomics</article-title>. <source>F1000Research</source>
<year>2014</year>, <volume>3</volume>, <fpage>113</fpage><pub-id pub-id-type="doi">10.12688/f1000research.4185.2</pub-id>.<pub-id pub-id-type="pmid">25383183</pub-id></mixed-citation></ref><ref id="ref87"><mixed-citation publication-type="journal" id="cit87"><name><surname>Maggiora</surname><given-names>G.</given-names></name>; <name><surname>Vogt</surname><given-names>M.</given-names></name>; <name><surname>Stumpfe</surname><given-names>D.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name>
<article-title>Molecular similarity
in medicinal chemistry</article-title>. <source>J. Med. Chem.</source>
<year>2014</year>, <volume>57</volume>, <fpage>3186</fpage>&#x02013;<lpage>3204</lpage>. <pub-id pub-id-type="doi">10.1021/jm401411z</pub-id>.<pub-id pub-id-type="pmid">24151987</pub-id></mixed-citation></ref><ref id="ref88"><mixed-citation publication-type="journal" id="cit88"><name><surname>Hu</surname><given-names>X.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Vogt</surname><given-names>M.</given-names></name>; <name><surname>Stumpfe</surname><given-names>D.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name>
<article-title>MMP-cliffs: systematic
identification of activity cliffs on the basis of matched molecular
pairs</article-title>. <source>J. Chem. Inf. Model.</source>
<year>2012</year>, <volume>52</volume>, <fpage>1138</fpage>&#x02013;<lpage>1145</lpage>. <pub-id pub-id-type="doi">10.1021/ci3001138</pub-id>.<pub-id pub-id-type="pmid">22489665</pub-id></mixed-citation></ref><ref id="ref89"><mixed-citation publication-type="journal" id="cit89"><name><surname>Stumpfe</surname><given-names>D.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name>
<article-title>Similarity searching</article-title>. <source>Wiley Interdiscip.
Rev.: Comput. Mol. Sci.</source>
<year>2011</year>, <volume>1</volume>, <fpage>260</fpage>&#x02013;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1002/wcms.23</pub-id>.</mixed-citation></ref><ref id="ref90"><mixed-citation publication-type="journal" id="cit90"><name><surname>Peltason</surname><given-names>L.</given-names></name>; <name><surname>Iyer</surname><given-names>P.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name>
<article-title>Rationalizing
three-dimensional activity
landscapes and the influence of molecular representations on landscape
topology and the formation of activity cliffs</article-title>. <source>J. Chem. Inf. Model.</source>
<year>2010</year>, <volume>50</volume>, <fpage>1021</fpage>&#x02013;<lpage>1033</lpage>. <pub-id pub-id-type="doi">10.1021/ci100091e</pub-id>.<pub-id pub-id-type="pmid">20443603</pub-id></mixed-citation></ref><ref id="ref91"><mixed-citation publication-type="journal" id="cit91"><name><surname>Geppert</surname><given-names>H.</given-names></name>; <name><surname>Horv&#x000e1;th</surname><given-names>T.</given-names></name>; <name><surname>G&#x000e4;rtner</surname><given-names>T.</given-names></name>; <name><surname>Wrobel</surname><given-names>S.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name>
<article-title>Support-vector-machine-based
ranking significantly improves the effectiveness of similarity searching
using 2D fingerprints and multiple reference compounds</article-title>. <source>J. Chem. Inf. Model.</source>
<year>2008</year>, <volume>48</volume>, <fpage>742</fpage>&#x02013;<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1021/ci700461s</pub-id>.<pub-id pub-id-type="pmid">18318473</pub-id></mixed-citation></ref><ref id="ref92"><mixed-citation publication-type="journal" id="cit92"><name><surname>Bajorath</surname><given-names>J.</given-names></name>; <name><surname>Peltason</surname><given-names>L.</given-names></name>; <name><surname>Wawer</surname><given-names>M.</given-names></name>; <name><surname>Guha</surname><given-names>R.</given-names></name>; <name><surname>Lajiness</surname><given-names>M. S.</given-names></name>; <name><surname>Van Drie</surname><given-names>J. H.</given-names></name>
<article-title>Navigating structure-activity
landscapes</article-title>. <source>Drug Discovery Today</source>
<year>2009</year>, <volume>14</volume>, <fpage>698</fpage>&#x02013;<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2009.04.003</pub-id>.<pub-id pub-id-type="pmid">19410012</pub-id></mixed-citation></ref><ref id="ref93"><mixed-citation publication-type="journal" id="cit93"><name><surname>Peltason</surname><given-names>L.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name>
<article-title>SAR Index: Quantifying the Nature
of Structure&#x02013;Activity
Relationships</article-title>. <source>J. Med. Chem.</source>
<year>2007</year>, <volume>50</volume>, <fpage>5571</fpage>&#x02013;<lpage>5578</lpage>. <pub-id pub-id-type="doi">10.1021/jm0705713</pub-id>.<pub-id pub-id-type="pmid">17902636</pub-id></mixed-citation></ref><ref id="ref94"><mixed-citation publication-type="weblink" id="cit94"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.scbdd.com/mopac-optimization/optimize/">http://www.scbdd.com/mopac-optimization/optimize/</uri> (accessed on November 18, 2020).</mixed-citation></ref><ref id="ref95"><mixed-citation publication-type="journal" id="cit95"><name><surname>Dong</surname><given-names>J.</given-names></name>; <name><surname>Cao</surname><given-names>D.-SC.</given-names></name>; <name><surname>Hong</surname><given-names>Y. M.</given-names></name>; <name><surname>Shao</surname><given-names>L.</given-names></name>; <name><surname>Bai</surname><given-names>C. D.</given-names></name>; <name><surname>Yong</surname><given-names>H. Y.</given-names></name>; <name><surname>Ning</surname><given-names>N. W.</given-names></name>; <name><surname>Ai</surname><given-names>P. L.</given-names></name>; <name><surname>Wen</surname><given-names>B. Z.</given-names></name>; <name><surname>Alex</surname><given-names>C.</given-names></name>
<article-title>ChemDes: an integrated web-based platform for molecular descriptor
and fingerprint computation</article-title>. <source>J. Cheminf.</source>
<year>2015</year>, <volume>7</volume>, <fpage>60</fpage><pub-id pub-id-type="doi">10.1186/s13321-015-0109-z</pub-id>.</mixed-citation></ref></ref-list></back></article>